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INTRODUCTION 
        Pain from surgery occurs as a result of tissue trauma and results in 
physical and psychological discomfort to the patients. There is a 
relationship between perioperative tissue damage and postoperative pain. 
Acute and sustained release of chemical mediators during peri-operative 
period leads to central sensitisation. This causes to acute pain become 
chronic pain. Avoiding the central sensitisation will help in decreasing 
the intensity of acute pain and in preventing this acute pain from 
becoming chronic. 
 Pre-emptive analgesia is a treatment strategy that starts before the 
surgery to prevent the establishment of central sensitisation due to 
incisional and inflammatory injuries. The concept of pre-emptive 
analgesia was practised by George Washington Crile in the early 1900s(1). 
He stated that trauma caused by surgery produced a “shock and 
exhaustion” to the central nervous system. Washington Crile advocated 
pre-incisional local anaesthetic infiltrations combined with general 
anaesthesia. By this way noxious stimuli were prevented from reaching 
the brain. Wall and Wolf suggested that the timing of analgesic treatment 
should be prior to the surgical incision. But this idea was not practised 
until the 1980s.  
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Pre-emptive analgesia can be provided by various methods like –  
- local infiltration,  
- nerve blocks, 
-  epidural blocks, 
-  subarachnoid blocks  
-  intravenous and oral drugs  
The drugs used for pre-emptive analgesia include 
- Opioids 
- NSAIDS 
- Ketamine 
- Gabapentin 
- Pregabalin 
- Recently Flupirtine 
Each drug has its own side effects like opioid induced respiratory 
depression and sedation, NSAID induced gastritis and ketamine induced 
hallucinations.  
 Flupirtine is a recently discovered non-opioid, non-NSAID 
centrally acting analgesic with indirect NMDA antagonist properties. It 
has the following advantages like  
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- Preservation of respiratory function 
- Better gastric tolerability 
- Good muscle relaxation 
- Anti-oxidant potential 
- Neuroprotective. 
Abdominal surgeries are the most painful procedure amongst 
surgical procedures(2). Pain is a uniquely individual experience and 
subjective. Patients who undergo abdominal surgeries will have 
hypoventilation, due to pain from surgical incision. This hypoventilation 
in turn will lead to post-operative hypoxia and result in increased 
morbidity. 
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AIM OF THE STUDY 
To Study the Efficacy of Pre-Emptive Oral Flupirtine on 
Postoperative Analgesia In Patients Undergoing Abdominal Surgeries 
Under General Anaesthesia 
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OBJECTIVES 
PRIMARY OBJECTIVES: 
To determine the efficacy and duration of postoperative analgesia 
after oral flupirtine administration as pre-emptive analgesic by using the 
time to first rescue analgesic requirement. 
SECONDARY OBJECTIVES: 
 To quantify the severity of postoperative pain in terms of 
numerical rating scale. 
 To use the Ramsey sedation score to assess sedative effect of 
flupirtine. 
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                                  REVIEW OF LITERATURE 
M.R. Afhami, P.Hassanzadeh, J. R. Panahea(3) conducted a 
study in 2006 titled “Pre-emptive Analgesia with Paracetamol 
(Acetaminophen) in Postoperative Pain”. They evaluated pre-emptive 
Paracetamol on postoperative analgesia in patients undergoing elective 
tubectomy. It was a prospective interventional study. Forty women 
scheduled for elective tubectomy with American society of 
Anaesthesiologists (ASA) physical status I were included in this study. 
Patients with liver disease, infections, giving history of alcohol intake and 
those patients on analgesic drugs were excluded from this study. These 
patients received 325mg of paracetamol tablet 30 minutes before the 
surgery. Patients were instructed about verbal rating scale preoperatively. 
All the patients underwent surgery under standard general anaesthesia. 
Increase in blood pressure and pulse rate were recorded as indicators of 
pain intraoperatively and in post anaesthesia care unit (PACU). Verbal 
rating score was noted in PACU in 3 situations like on rest, coughing, on 
movement. The results showed that 50% of patients felt mild and 
moderate pain at resting position. 40% of patients felt mild pain and 60% 
of patients felt moderate pain on moving status. 90% of patients felt 
moderate pain on coughing. None of the patients felt severe pain in all 
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three situations. At the end of surgery 90% of patients said they will 
prefer pre-emptive analgesia in future. 
 Harsimran Singh et al(4) conducted a study to evaluate the pre-
emptive analgesic effect of ketamine in patients undergoing laparoscopic 
cholecystectomy surgery. They randomly divided 80 patients who posted 
for laparoscopic surgery into four groups with 20 patients in each group. 
Patients in group A received 1mg/kg of intravenous ketamine 30minutes 
before incision. Group B and Group C patients received 0.75mg/kg and 
0.5mg/kg of IV ketamine respectively. Patients in Group D received 
isotonic saline. All patients underwent surgery under general anaesthesia. 
In the postoperative period all patients were monitored for visual 
analogue scale (VAS) at rest, on movement and on deep breathing at 
specified intervals. If visual analogue scale was more than 5, fentanyl 
1mcg/kg IV was given as rescue analgesia. They also noted total opioid 
rescue analgesic dose and postoperative nausea and vomiting. The results 
showed that the VAS score was higher in group D as compared with 
group A, group B and group C. Total opioid consumption was also 
decreased in group A and group B patients. Heart rate and blood pressure 
were initially high in group D patients with mild hallucination on 
emergence. The study concluded that pre-emptively given ketamine 
effectively controls the postoperative pain in laparoscopic 
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cholecystectomy surgeries. It also decreased opioid consumption in the 
postoperative period. The low dose 0.5mg/kg ketamine does not cause 
any adverse effects and haemodynamic changes and it is an optimal dose 
for pre-emptive analgesia in these surgeries. 
 Naser sm et al(5) performed a study in 2012 to evaluate the safety 
and efficacy of flupirtine 100mg and tramadol 50mg in postoperative pain 
management. They selected 113 postoperative patients for this study. Of 
these 104 patients met inclusion criteria. These 104 patients were 
randomly divided into two groups. One group received oral flupirtine 
100mg thrice daily for five days. Another group received tramadol 50mg 
orally thrice daily for 5 days. Intensity of pain was assessed using visual 
analogue scale and side effects were noted. At the end of study the results 
showed that visual analogue score was significantly (P=0.001) decreased 
in the flupirtine group with almost equivalent efficacy to that of tramadol 
group. The incidences of side effects were less (7.4%) in both groups. 
Both drugs were assessed as good. The study concluded that 100mg oral 
flupirtine provides equal pain relief as tramadol 50mg for postoperative 
analgesia, which might be beneficial effect for avoiding the side effects of 
non- steroidal anti-inflammatory and opioid drugs. 
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 P.Mastronardi et al(6) did a study to evaluate the postoperative  
analgesic effect of flupirtine in orthopaedic surgeries. They compared the 
flupirtine with diclofenac sodium for analgesic potency. It was a double 
blinded randomised controlled study. Forty patients scheduled for 
elective orthopaedic surgeries were selected for the study. All these 
patients were above 18 years of age. All these patients underwent surgical 
procedures under regional anaesthesia. Then they were shifted to 
postanaesthesia care unit (PACU). In PACU, they were randomly divided 
into two groups. When they requested analgesia, one group was treated 
with flupirtine 100mg and another group was treated with diclofenac 
sodium 50mg. Both drugs were administered orally. The next analgesic 
dose was repeated after 45mins of previous dose with maximum 4 
capsules per day. Patients were excluded from the study if they requested 
analgesia with in 45mins interval, and those patients who had taken more 
than 4 capsules per day. They assessed intensity of pain using visual 
analogue scale at 30mins and 60mins after the drug administration. They 
also noted the total number of capsules administered, side effects and 
patient’s satisfaction score. The results showed that the mean total 
number of capsules taken for flupirtine it was 2.3±0.8 and for diclofenac 
it was 2.7±0.5. There was no significant change noted in pain scores for 
first two doses. The pain score for third dose was significantly (p=0.02) 
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low in flupirtine group. The study concluded that flupirtine 100mg 
provides analgesia similar to diclofenac sodium 50mg with fast onset and 
better duration.  
 Alaa El Deeb, Gamal Z. El-Morsy(7) conducted a study in 2011 
titled “Comparison of pre-emptive analgesic effect of intravenous 
ketorolac versus tramadol in paediatric inguinal herniotomy: A 
randomized double blind study”. He selected 80 children between 2-12 
years and randomly allocated them into two groups with 40 children in 
each group – Group T and Group K. Group T received intra-venous 
tramadol 1mg/kg and Group K received intra-venous ketorolac 1mg/kg 
after induction of general anaesthesia. He monitored time to first 
analgesia, requirement for supplemental analgesics and sedation level. 
The time to first analgesic was significantly longer and the requirement to 
subsequent analgesics was significantly lower in the Group T compared 
to Group K. There were no adverse effects reported in the study in both 
the groups. 
 Mustafa arslan et al(8) conducted a study titled “Comparing the 
efficacy of pre-emptive intravenous paracetamol on the reducing effect of 
opioid usage in cholecystectomy”. The study was conducted in 300 
patients scheduled for laparoscopic cholecystectomy with ASA physical 
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status I and II. These patients were randomly allocated into three groups 
with 100 patients in each group. Patients in group I were given 
paracetamol 1g intravenously 10 minutes before surgery then 100 ml 
normal saline after completion of surgery. Patients in group II were given 
100ml normal saline intravenously 10minutes before surgery then 
paracetamol 1g in 100ml was given after completion of the surgery. 
Patients in group III have received 100ml of normal saline 10 minutes 
before surgery and then 100ml normal saline was given after completion 
of the surgery. In the postoperative period these patients were observed 
for visual analogue score (VAS) to identify intensity of pain. VAS was 
observed at 15th min, 30th min, 1st, 2nd, 4th, 6th, 8th, 12th, 18th and 24th hour. 
If visual analogue score was more than 4, tramadol 100mg was given 
intravenously as rescue analgesia with maximum dose of 400mg per day. 
They also observed time to first rescue analgesia, patient satisfaction 
score and side effects. The results showed that visual analogue scale score 
observed at 15th, 30th  minutes 1st hour ,4th hour ,6th hour ,8th hour ,18th 
hour were higher in group III patients  who had received normal saline. 
But it was lower in group I patients. VAS score observed at 30 minutes 
and 1st hour were higher in group II than group I patients. Time to first 
rescue analgesia was significantly longer in duration in group I and group 
II patients who had received intravenous paracetamol than group III. The 
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study concluded that pre-emptively given paracetamol effectively control 
the postoperative pain in laparoscopic cholecystectomy. 
 Parviz Kashefi, Azim Honarmand, Mohammadreza Safavi(9) 
conducted a study in 2003 to compare the pre-emptive analgesic effect of 
acetaminophen and celecoxib on postoperative pain relief in lower limb 
orthopaedic surgery. This study was a prospective randomised double 
blind study. 90 patients posted for lower limb orthopaedic surgery were 
included in this study .These patients were aged between 18 to 65 years 
with ASA physical status I and II. These patients were randomly divided 
into three groups with 30 patients in each group. Patients with gastritis, 
elevated renal and liver function test were excluded from this study. 
Patients in group C received celecoxib 200mg orally 2 hours before 
surgery. Patients In group P received placebo drug. Patients in group A 
received acetaminophen 320mg. All these drugs were administered to the 
respective group of patients 2 hours before surgery. All these patients 
underwent surgery under general anaesthesia. In the postoperative period 
patients were observed for visual analogue score, duration of PACU stay, 
and side effects. Rescue analgesic Morphine 0.05mg per kg iv was given 
if VAS was more than 4 .The results showed that VAS score at 4th hour 
was significantly lower in celecoxib group than in paracetamol group. 
There were no significant changes noted in VAS score at 12th and 24th 
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hour of postoperative period in all three groups. The incidences of side 
effects were similar in all three groups. 
 Jing lu and colleague(10) conducted a study named “Effect of pre-
emptive analgesia with parecoxib sodium in patients undergoing radical 
resection of lung cancer”. The study was conducted in patients 
undergoing radical resection of lung cancer surgery under general 
anaesthesia. 115 patients with American society of Anaesthesiologist 
physical status I and II were included in this study. They were randomly 
divided into groups. Patients in research group received 40 mg parecoxib 
IV preoperatively then 2ml of normal saline postoperatively. Patients in 
control group received 2ml of normal saline IV preoperatively, then 40 
mg parecoxib IV postoperatively. All these patients underwent surgery 
under standard general anaesthesia care and monitoring. Postoperatively 
these patients were observed for visual analogue score to assess the pain 
in the following interval 1st, 2nd, 4th, 8th, 12th, 24th and 48th hour. They also 
observed emergence agitation, using agitation score .The results showed 
that the visual analogue scale score was significantly less in research 
group patients who had received parecoxib pre-operatively. The agitation 
score was significantly lower in the research group than control group. 
The study concluded that pre-emptive parecoxib was most effective in 
14 
 
controlling acute and postoperative pain in radical resection of lung 
surgery. It also reduces emergence agitation significantly. 
 H.Unlugenc et al(11) conducted a study in 2009 “Pre-emptive 
analgesic efficacy of tramadol compared with morphine after major 
abdominal surgery”. They compared the pre-emptive analgesic effect of 
tramadol and morphine in patients undergoing abdominal surgeries. 90 
patients scheduled for major abdominal surgery were included in this 
study. These patients were aged between 21 to 58 years with ASA 
physical status I and II. These 90 patients were divided randomly into 
three groups. Patients in group T received tramadol 1mg per kg 
intravenously. Patients in group M received morphine 0.1mg per kg. 
Patients in group S received 0.9% normal saline. All these drugs were 
given after induction of anaesthesia, intravenously. All these patients 
were instructed on use of patient controlled analgesia device before 
surgery. All patients underwent surgery under general anaesthesia. In the 
postoperative ward pain management was done through PCA with 
morphine 0.025mg per kg loading dose. The lockout time was 20 
minutes. They calculated total dose of morphine, 11 point numerical 
rating scale to assess the discomfort, as well as visual analogue scale 
score to assess the pain at 1st hour, 2nd hour, 4th hour, 6th hour, 12 and 24th 
hour of postoperative period. Mepiridine 0.4mg per kg was given as 
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rescue analgesia. The study results showed total morphine requirement in 
group M was significantly lower at 12 and 24th hour of surgery. In group 
T it was low only at 24th hour. No other significant differences were noted 
in other variables. The study concluded that pre-emptively given tramadol 
produced similar pain relief, recovery time and morphine requirement as 
compared with pre-emptive morphine. 
 Thapa D et al(12) conducted a study in patients undergoing total 
abdominal hysterectomy under general anaesthesia to evaluate 
postoperative morphine sparing effect of pre-emptive flupirtine. It was a 
prospective randomised controlled study. 50 female patients posted for 
total abdominal hysterectomy were included in this study. These patients 
were aged between 30 and 60 years with American society of 
anaesthesiologist physical status I and II. Patients were randomly divided 
into two groups with 25 patients in each group. Group flupirtine patients 
received 100mg flupirtine orally 1 hour before surgery. Placebo group 
patients received placebo drug orally 1 hour before surgery. Both groups 
of patients underwent hysterectomy under standard general anaesthesia. 
Postoperative pain was managed with patient controlled analgesia using 
morphine. PCA setting was morphine 0.1 mg/kg of loading dose with 7 
minutes lockout time interval. They monitored total dose of morphine 
consumption at 48 hours of surgery. They also noted hemodynamic 
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changes, visual analogue scale score at rest, VAS on cough and side 
effects. The study results showed that the mean value of total morphine 
requirement at 48 hours of surgery was lower in flupirtine group than 
placebo group. The mean value of VAS at rest and on cough was also 
decreased in flupirtine group.  
 Yadav et al(13) conducted a study titled “Evaluating the role of 
flupirtine for postcraniotomy pain and compare it with diclofenac 
sodium: a prospective, randomized, double blind, placebo-controlled 
study”. The study was conducted in patients undergoing elective 
craniotomy surgery under general anaesthesia. 390 patients were selected 
for this study. The study patients were aged between 18 and 70 years with 
ASA physical status I and II. These patients were randomly divided into 
three groups with 130 patients in each group. Patients in group I were 
administered placebo drug. Patients in group II received 50mg diclofenac 
tablet. Patients in group III received 100mg flupirtine capsule. All these 
drugs were given 8th hourly for 48 hours in the postoperative period. They 
observed visual analogue scale score for assessing the pain, level of 
sedation and side effects. 19 patients dropped out from the study for 
various reasons. The study was carried and analysed with remaining 371 
patients. The study results showed that visual analogue scale score was 
significantly low in flupirtine and diclofenac group patients. Pain relief 
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observed in diclofenac, flupirtine, control groups were 90.5%, 90.2% and 
69.8% respectively. The rescue analgesic requirements were significantly 
less in diclofenac and flupirtine group patients as compared to the control 
groups. 
 Ligio yang et al(14) conducted a study titled “Pre-emptive 
analgesic effects of ketamine in patients undergoing surgery” They 
analysed articles of randomised controlled studies done for pre-emptive 
analgesic effect of ketamine from pubmed, Cochrane library, EMBASE 
websites. They did five studies, and included 266 patients in their meta-
analysis. The results showed that pre-emptive ketamine significantly 
reduced the morphine requirement in the postoperative period and also 
prolonged the time to first rescue analgesia.  
 Usha bafna et al(15) conducted a study to compare the 
postoperative analgesic effect of gabapentine and pregabalin given orally 
1hour before the surgery. This study was conducted in patients scheduled 
for gynaecological surgeries under spinal anaesthesia. These patients 
were aged between 30 and 50 years with ASA physical status I and II. 
Totally 90 patients were included in this study. They were randomly 
divided into three groups (group A, B, C) with 30 patients in each group. 
Patients in group A received identical placebo drugs. Patients in group B 
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received Gabapentine 600mg. Patients in group C received pregabalin 
150mg. All these three drugs were given orally to the concerned patients 
before one hour of surgery. They assessed visual analogue scale score, 
onset of sensory and motor block by pin brick and bromage scale 
respectively. The time to first rescue analgesia was also noted. The results 
showed that the mean duration of effective analgesia was longer in group 
C as compared to other groups. The mean rescue analgesia dose 
requirements were also decreased in group C. The study concluded that 
pre-emptively given gabapentin and Pregabalin significantly decrease 
rescue analgesic requirements in postoperative period. 
 Constantance anne cabel et al(16) conducted a study to evaluate 
analgesic effect of pre-emptive ketorolac in laparoscopic ambulatory 
surgeries. It was a prospective randomised study. 51 women posted for 
laparoscopic gynaecological surgery with American society of 
Anaesthesiologist physical status I and II were included in this study. 
Women age included in this study were between 18 and 65 years. They 
were randomly divided in two groups by computer generated number. 
Women in group I were administered ketorolac 30mg intravenously 
before starting of surgery. Then 1ml of sodium chloride saline was given 
intravenously at the end of surgery. Women in group II were 
administered 1ml of sodium chloride saline intravenously before starting 
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of the surgery. Then 30 mg ketorolac was given intravenously at the end 
of surgery. All the women underwent laparoscopic gynaecological 
surgery under general anaesthesia. In PACU intensity of pain was 
analysed using visual analogue scale score in 15minutes interval for 
1hour then 30 minutes interval until the patient was discharged from 
hospital. Fentanyl was used as rescue analgesia. Fentanyl 25mcg or 
30mcg was given intravenously if patients VAS score was above 4. 
Morphine 2mg IV was used as a second rescue analgesia. The study 
results showed that according to VAS score, patients in ketorolac group 
were experienced less pain at the end of surgery. No other significant 
variables were noted in this study. 
 Ambrish Sharma et al(17) conducted a study in 2015 titled “A 
comparative study of efficacy and safety of flupirtine versus piroxicam in 
patients with low back pain”. It was a randomized controlled prospective 
study. 74 patients of either sex with low back pain were included in this 
study. They were randomly divided into two groups with 37 patients in 
each group, named group I and group II. Patients in group II received 
flupirtine 100mg twice a daily for 14 days. Group II patients received 
20mg piroxicam twice a daily for 14 days. 30 patients from each group 
completed the study. They assessed Finger-to-Floor Distance (FFD, 
Lasegue’s sign), lumbar pain and pain in lower limbs, tenderness of 
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vertebral muscles and sensory disturbance in lower limb. The results 
showed that both the drugs were equally effective in alleviating the pain 
but flupirtine has better tolerability than the piroxicam.  
 R.A.Moore et al(18) conducted a study titled “Comparison of 
flupirtine maleate and dihydrocodeine in patients following surgery”. 
They included fifty women who undergoing transabdominal 
hysterectomy surgery. Women more than 18 years of age were included 
in this study, weight between 45kg to 90kgs. These women were 
randomly divided into two groups. Women in flupirtine group received 
flupirtine 100mg and two placebo drugs which resembled dihydrocodeine 
for 3 days. Women in dihydrocodeine group received two tablets 
dihydrocodeine 30mg and one placebo drug which resembles flupirtine 
for 3 days. The study was started after the surgery and continued for 3 
days. In this study period women requiring analgesia received study 
drugs in 4 hours interval. Injection papaveretum intramuscularly was used 
as rescue analgesia between these intervals. The analgesia was assessed 
by using four point scale, assessed at 8.30hour and at 16.30hour on every 
day for 3 days. The results showed the analgesic efficacy produced by 
both drugs was similar in both groups. But women in flupirtine group 
experienced more depression than dihydrocodeine. Women in 
dihydrocodeine group experienced more sleepiness than flupirtine group. 
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 Lian-Dong Wang et al(19) conducted a study titled “Effects of Pre-
emptive Analgesia with Parecoxib Sodium on Haemodynamics and 
Plasma Stress Hormones in Surgical Patients with Thyroid Carcinoma” It 
was a prospective randomised controlled study. Fifty seven patients 
having thyroid carcinoma posted for thyroidectomy surgery were 
included in this study. These patients were randomly divided into three 
groups with nineteen patients in each group. Patients in control group 
received 0.9% normal saline injection before induction of anaesthesia. 
Patients in trial group I were injected with parecoxib sodium 
intravenously twenty minutes before induction. Patients in trial group II 
were also injected with parecoxib sodium injection 12 hours after 
surgery. They measured cortisol level, plasma norepinephrine, blood 
glucose level 12 hours before surgery and 24 hours after surgery. They 
also assessed visual analogue scale at 4hour, 8hour, 12 hour and 24 hour 
after surgery. Haemodynamic changes were recorded before surgery, 
after surgery and 12, 24 hours after surgery. The results revealed, the 
norepinephrine and cortisol level were increased in all three groups after 
12 and 24 hour of surgery, But it was slightly lesser in group II patients. 
Visual analogue scale score were markedly lower in both trial groups 
than control groups. The study concluded that pre-emptive parecoxib 
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administration before surgery and after surgery can reduce the stress 
hormone levels in the blood and has better analgesic effects. 
 Joginder pal attri et al(20) compared oral flupirtine and oral 
diclofenac sodium for postoperative analgesia and its side effects on 
patients undergoing elective abdominal surgeries. It was a prospective 
randomised double blinded study. Hundred patients were selected and 
divided into two groups with fifty patients in each group. Patients in 
group A received flupirtine 100mg sixth hourly for five days after the 
surgery. Patients in group B received 50mg diclofenac sodium sixth 
hourly for 5 days after the surgery. They assessed for visual analogue 
scale score and side effects of both drugs in the postoperative period. The 
study concluded that oral flupirtine and diclofenac sodium were equally 
effective for pain relief in the postoperative period. But oral flupirtine had 
minimal side effects and was well tolerated compared to diclofenac 
sodium. 
 Shang non wu and collegue(21) did a study to reveal the inhibitory 
effects of flupirtine on delayed rectifier K+ currents in motor neuron like 
cells. In their study they evaluated the effects of flupirtine on ion currents 
in NSC 34 neuroblastoma hybrid cells and NG108-15 neuronal cells. 
Exposure of flupirtine to these cells produced inhibitory actions on 
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delayed rectifier K+ current in a concentration and state dependent 
fashion. 
 Ghanshyam yadav et al(22) conducted a study to reveal the pre-
emptive analgesic effect of flupirtine in patients undergoing laparoscopic 
cholecystectomy. The study was a prospective randomised controlled 
study. Eighty patients posted for laparoscopic cholecystectomy were 
included in this study. They were randomly divided into two groups with 
40 patients in each group. Group F patients received flupirtine 200mg 
orally two hours before surgery. Patients in group B received capsules of 
B complex vitamins two hours before surgery. Acute postoperative pain 
was assessed in terms of visual analogue scale score, and sedation was 
assessed by using Ramsey sedation score. The primary outcome of this 
study assessed the severity of postoperative pain using visual analogue 
scale score, duration of analgesia was assessed by calculating the time to 
first rescue analgesic requirement. The result showed that visual analogue 
scale score was lower in flupirtine group than the control group. The time 
to first rescue analgesia was longer in duration in flupirtine group than the 
control group. 
 R.million et al(23) conducted a study titled “Clinical trial of 
flupirtine maleate in patients with migraine” They compared analgesic 
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effects of flupirtine and paracetamol in patients with migraine. It was a 
randomised double blind parallel study conducted in 40 patients. Patients 
were randomly divided into two groups with 20 patients in each group. 
Patients in one group were treated with flupirtine 100mg orally with 
maximum four doses per day for five days.  Patients in another group 
were treated with paracetamol 1g orally for 5 days with maximum 4 
doses per day. These patients were observed for visual analogue scale 
score to assess the pain and side effects. In flupirtine group VAS score 
initially was high but VAS score trend was subsequently lower. 
Insignificant side effects were noted in both groups. 
 Roopesh jain et al(24) conducted a randomised double blind 
controlled trial study in carcinoma breast surgery patients to reveal 
whether morphine requirements were decreased after the use of flupirtine. 
They evaluated the efficacy of flupirtine in decreasing the morphine 
requirements in patients who underwent breast carcinoma surgery. Fifty 
patients posted for carcinoma breast surgery were included in this study. 
These fifty patients were randomly divided into two groups with 25 
patients in each group. After the surgery the pain managed with patient 
controlled analgesia using morphine. The setting of patient controlled 
analgesia was 1mg bolus with 5minutes lockout time. Maximum dose 
was 8mg per hour. Patients in flupirtine group received flupirtine 100mg 
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orally two hours before surgery and first postoperative day morning. 
Control group received placebo drugs 2 hours before surgery and first 
postoperative day morning. They noted the total morphine dose and 
numerical rating scale score at rest, on movement of the patient. Pain 
score was noted for 48 hours with 6 hours interval. They also observed 
adverse effects. The results showed the average total morphine dose for 
first 24hours in flupirtine group was 12.9mg and in placebo group it was 
19.8mg at 48 hours of surgery. When compared to the placebo group, 
morphine requirement was significantly lower in flupirtine group.  
 Vanitha ahuja et al(25) conducted a study in women posted for 
ambulatory gynaecological surgery to reveal analgesic efficacy of 
flupirtine and ibuprofen. It was a randomised controlled prospective 
study. The study was conducted in 60 women posted for ambulatory 
gynaecological surgery. The women with American society of 
anaesthesiologist physical status I and II were included in this study. 
These 60 women were randomly divided into two groups with 30 women 
in each group. Women in flupirtine group were administered flupirtine 
100mg per orally one hour before surgery, then every 8hours for 48 
hours. Women in the ibuprofen group were administered ibuprofen 
800mg per orally 1 hour before surgery then 8 hourly for 48 hours. All 
women in both groups underwent surgery for short duration under general 
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anaesthesia. Postoperatively pain was assessed using verbal numerical 
rating scale score at two hours interval for first 8 hours. After discharge 
from hospital, patients were contacted through phone to assess the pain 
using verbal numerical rating scale score at 12 hours interval for 48 
hours. The patient satisfaction score was also assessed at 24th hour and 
48th hour. The results showed that when compared to the ibuprofen group, 
verbal numerical rating scale score (VNRS) at 2nd hour of postoperative 
period was significantly decreased in flupirtine group. VNRS at 4th, 6th, 
8th, 12th and 24th hours were similar in both groups. The patient 
satisfaction score was also high in flupirtine group.  
 Amiya K. Mishra et al(26) reviewed recent published evidences to 
assess the efficacy of pre-emptive analgesia concept. They reviewed case 
reports, randomised controlled trials, research articles, meta-analysis, 
reviews on pre-emptive analgesia from pubmed, Medscape Medline from 
1993 to 2013. These publications showed pre-emptive use of intravenous 
NSAID with low dose of ketamine intravenously provide adequate 
postoperative analgesia. Ketamine alone used pre-emptively does not 
provide adequate analgesia in the postoperative period. Pre-emptive 
administration of local anaesthetics to incisional site, postincisional 
administration of LA and peritoneal administration of LA all produce 
similar efficacy of analgesia in the postoperative period. Epidural 
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analgesia given pre-emptively has good control over the perioperative 
immune function and adequate pain relief similar to parenteral opioids. 
Pre-emptive gabapentin and pregabalin provided adequate postoperative 
analgesia with anxiolytic effect. 
 Na wang et al(27) did a study in patients scheduled for transurethral 
resection of prostate to assess the efficacy of pre-emptive ketamine in 
reducing the postoperative pain in these patients. It was a prospective 
randomised controlled study. Sixty patients with American society of 
anaesthesiologist physical status I and II were included in this study. 
They were randomly divided into two groups with 30 patients in each 
group. Patients in ketamine group were administered 0.5mg per kg of 
ketamine intravenously 10 minutes before surgery. Control group was 
administered 0.9% normal saline in equal volume intravenously 
10minutes before surgery. All patients underwent transurethral resection 
of prostate under general anaesthesia using laryngeal mask airway. In the 
postoperative period all these patients were monitored for pain using 
visual analogue scale score to assess the intensity of pain for 24 hours. 
Injection tramadol 1.5mg per kg was given as rescue analgesia if the 
visual analogue scale score was more than 3. They also noted down, 
incidence of discomfort in operated site, total tramadol dose, side effects, 
and sedation level using Ramsey sedation score. The study results 
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showed that patients in ketamine group had significantly lower VAS 
score in the postoperative period. Total tramadol dose requirement was 
also lower in ketamine group than in the control group. There was no 
significant difference in incidence of discomfort in the operated site and 
side effects in both groups. 
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PAIN  
DEFINITION 
 Pain is defined as “An unpleasant emotional and sensory 
experience associated with actual or potential tissue damage or described 
in terms of such damage” – International association for study of pain 
(IASP). 
TYPES OF PAIN 
Various classifications are available for pain. 
Cervero and Laird (1991)(28) classified 3 types of pain: 
1. Acute physiological nociceptive pain. 
This type of pain protects the tissue from being damaged further due 
to withdrawal reflexes which occur.  
2. Pathophysiological nociceptive pain: 
This type of pain occurs during inflammation or injury to the tissue. 
It may present as spontaneous pain or allodynia and hyperalgesia. 
Spontaneous pain appears without any intentional stimuli or 
inflammation. 
Hyperalgesia severe pain intensity, felt during noxious stimuli. 
Allodynia means, a stimulus that is below the pain threshold elicits 
sensation of pain. 
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3. Neuropathic pain: It is due to damage or dysfunction of the neurons 
in the central or peripheral nervous system. Its character is electrical 
or often burning in nature. It may combine with allodynia or 
hyperalgesia. 
 All nociception causes pain. But all pain does not result from 
nociception. Some patients experience pain without noxious stimulus. 
Therefore clinically pain is divided into two types: 
1. Acute pain (primarily due to nociception) 
2. Chronic pain (behavioural and psychological factors also play 
major role) 
 Pain is also classified according to: 
 Pathophysiology (nociceptive or neuropathic pain) 
 Affected area (low back pain or headache) 
 Etiology (cancer pain or arthritis) 
1. ACUTE PAIN : 
 This type of pain is caused by noxious stimulus due to injury, 
abnormal function of the muscle and a disease process. Physiological 
processes such as transduction, transmission, modulation, and perception 
are involved. It’s most common forms are postoperative, posttraumatic, 
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and obstetric pain. Most of the acute pains are self-limited and subside 
with treatment in few days to weeks. When pain fails to subside due to 
improper treatment or abnormal healing, acute pain becomes chronic. It is 
a fast, sharp and pricking type of pain. It occurs rapidly and felt within 
0.1 second of pain stimulus application. It is carried by myelinated large 
Aδ nerve fibers. This pain is carried in a speed of 12 to 30 m/s. example: 
surgical incision and needle stick injury. This fast pain is not felt in most 
of the deeper tissues. 
2. CHRONIC PAIN: 
 Chronic pain is pain persisting for more than 6 months. It may be 
nociceptive, neuropathic or both. An important feature of this pain is 
environmental and psychological factors play a significant role. Patients 
affected by this pain have decreased or absent neuroendocrine stress 
response and sleep or mood disturbances. It is a slow, burning and aching 
type of pain. It gradually increases in intensity and carried by 
unmyelinated, small diameter C fibers in a speed of 0.5 to 2m/s. This pain 
is usually associated with tissue destruction that leads to prolonged and 
unbearable suffering. It occurs in both skin and deeper tissues. 
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BASED ON LEVEL OF STIMULATION: 
 Pain is classified into somatic pain and visceral pain. Both are 
subtypes of acute pain.  
Somatic pain:  
 It is further divided into superficial and deep. Superficial somatic 
pain is caused by nociceptive stimulus arising from skin, mucous 
membrane, and subcutaneous tissue. It is localised and described as 
sharp, pricking or burning in nature.  
 Deep somatic pain arises from muscle, joints, tendons and bones. It 
differs from superficial pain that, it is less well localised and dull aching 
nature. Both intensity and duration of stimulus affect the localisation. 
Visceral pain: 
 It is caused by disease or abnormal functions involving the internal 
organs or its coverings. Four subtypes:  
(1) True localized visceral pain,  
(2) Localized parietal pain, 
(3) Referred visceral pain,  
 (4) Referred parietal pain 
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 True visceral pain is dull aching and diffusely felt usually in the 
midline. It is commonly due to abnormal sympathetic or parasympathetic 
activity leads to nausea, sweating, vomiting and changes in the vitals. 
 Referred pain means the visceral pain felt in the cutaneous region 
which results from patterns of embryological formation and migration of 
tissues, and the convergence of somatic and visceral afferent input into 
the CNS. 
NON INFLAMMATORY PAIN: 
 Psychological pain is an unpleasant feeling of sensory and 
emotional experience with non- physical or inflammatory origin.  
PAIN RECEPTORS: 
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 The free nerve endings are responding to the damaged tissue, and 
transmit the noxious stimuli to the spinal cord. These free nerve endings 
are called nociceptors. These nociceptors are widespread in superficial 
layers of skin and certain internal tissues like periosteum, the joint 
surfaces, arterial walls and falx tentorium in the cranial vault. Most of the 
other deep tissues have sparsely supplied nerve endings. Any widespread 
damage to these areas can summate the impulses leading to chronic slow 
dull aching pain. The stimulation of nociceptors correlates with rate of 
damage than total tissue damage.  
Stimuli for nociceptors: 
1. Mechanical stimuli 
2. Thermal stimuli 
3. Chemical stimuli. (Bradykinin, prostaglandin, substance P, 
histamine) 
 Usually mechanical and thermal stimuli cause acute fast type of 
pain. Slow pain is elicited by all three stimuli.  
 Chemicals that elicit pain are bradykinin, histamine, serotonin, 
potassium ions, acids and proteolytic enzymes. In addition to this, 
prostaglandins and substance P increase the sensitivity of nerve endings 
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and they do not directly elicit free nerve endings. These chemical 
mediators usually are responsible for stimulating slow chronic suffering 
type of pain especially after tissue damage. 
PAIN PATHWAY: 
Pain pathway 
 Injury or Noxious stimuli to human body cause damage to the skin, 
capillary vessels and platelet. These damaged tissues release chemical 
mediators like bradykinin, prostaglandin, serotonin, substance P, 
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histamine and leukotrienes. These chemical mediators stimulate and 
sensitize the free nerve endings called nociceptors. The low intensity 
stimuli activate nociceptor through bradykinin and prostaglandin. 
 
Chemical mediators involved in pain stimulation 
 Histamine and serotonin directly stimulates the nerve endings. All 
other chemical mediators stimulate nociceptors by binding with receptor 
membrane and activating the second messengers. 
 These activated nociceptive free nerve endings act like transducers 
to convert mechanical, thermal and chemical energy to electrical activity 
.This electrical activity is conducted to dorsal horn of spinal cord via 
afferent nerve fibers (Aδ & C). In the dorsal horn of spinal cord 
(substantia gelatinosa and laminae), pain electrical activity is transmitted 
to the second order neurons from nociceptors. There are two types of 
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neurons in dorsal horn named nociceptive specific neuron and wide 
dynamic range neuron. These two neurons involved in response to and 
further signal the pain sensation to brain. Nociceptive specific neuron 
responds to impulses from nociceptive fibers (Aδ & C). But dynamic 
range neuron responds to nociceptive and non- nociceptive fibers (Aβ). 
 
Pain pathway in spinal cord level 
 The neurotransmitters involved in conducting the impulses in 
dorsal horn are aspartate, glutamate and substance P. These 
neurotransmitters act on NMDA receptor and AMPA (2-amino-3-
hydroxy- 5-methyl-4-isoxazole-propionic acid) Receptors. From second 
order neurons pain signals are transmitted to higher cortical centres 
through spinothalamic tract. 
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 This spinothalamic tract has two pathways named 
neospinothalamic tract and paleospinothalamic tract. AϨ fibers mainly 
transmit the fast acute pain to the spinal cord. Here these fibers terminate 
mainly within lamina I of dorsal horns. These fibers stimulate second 
order neurons of the neospinothalamic tract. Neospinothalamic tract 
carries signals to the thalamus, post central gyrus and midbrain. The slow 
pain conducting C fibers terminate in substantia gelatinosa(lamina II,III) 
of spinal cord. Here they excite second order neurons of 
Paleospinothalamic tract. This Paleospinothalamic tract carries signals to 
the reticular formation, limbic system, midbrain and pons. Parts of brain 
involved in perception and interpretation of pain are cortex (post central 
gyrus), reticular formation, limbic system, thalamus and hypothalamus. 
Efferent pathways composed of fibers connecting the midbrain, reticular 
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formation and substantia gelatinosa are involved in modulating the pain 
sensation.  
CENTRAL SENSITISATION: 
 
Mechanism of central sensitisation 
 Central sensitization “refers to the process by which sustained or 
repeated stimulation of primary afferent fibers results in prolonged 
neuronal hyper excitability in the dorsal horn of the spinal cord”. 
 Acute noxious stimuli (surgical incision) cause some changes in 
the central nervous system. These changes lead to hypersensitivity to 
pain. Stimuli from surgical incision and injury create various alterations 
and modulations in both central and peripheral pain pathway. A tissue 
damage activates local inflammatory response which results in release of 
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pain inducing substances from nerve endings and from extra neural 
sources. These substances cause peripheral sensitisation of nociceptors, 
results in altered transduction and increased number of impulses 
conducted to the central nervous system thereby causing peripheral 
sensitisation.  
 
 In dorsal horn, barrage of pain impulses from nociceptors to the 
wide dynamic range and nociceptive specific neurons lead to prolonged 
changes in responsiveness of these neurons. These changes lead to 
impulses from fast conducting (AϨ) and slow conducting nerve fibers 
being amplified (hyperalgesia). 
 
 
  
 
 
 
 
 
PRE-EMPTIVE ANALGESIA 
  
41 
 
PRE-EMPTIVE ANALGESIA 
DEFINITION 
 It is a treatment, initiated before the surgery to prevent emergence 
of central sensitisation caused by incision and inflammatory injuries 
occurring during surgery and in early postoperative period. 
 The term pre-emptive analgesia was coined by WALL(29). He 
suggested that administration of local anaesthetics and opioids prior to 
surgery decreases central neural effects of C fibers inducing injury 
barrage associated with surgical incision, and thereby local anaesthetics 
would decreases the intensity of postoperative pain.  
 Pre-emptive analgesia is based on the inhibition of central 
sensitisation formation. Noxious stimuli due to surgical incision induce a 
state of central nervous system hyperactivity that leads to pain 
accentuation. Routine clinical methods of analgesia may not provide 
adequate analgesia and prevention of central sensitisation during surgery 
and in postoperative period (Figure A). Even though postsurgical 
analgesia decreases nociceptive input to CNS in the postoperative period 
it does not provide adequate analgesia, because noxious stimuli 
developed during incision and perioperative period hypersensitises the 
42 
 
higher centre, So minimal nociceptive impulse will cause hyperalgesia in 
postoperative period (figure B).  
 
 Pre-emptive analgesia decreases nociceptive impulse during 
incision and perioperative period thereby preventing the 
hypersensitisation. Therefore analgesia in perioperative and postoperative 
period is adequate and better in pre-emptive analgesia (figure C). 
 Even though general anaesthesia may decrease the transmission of 
noxious impulses to central nervous system from injury site it does not 
block the impulses completely. Systemically used opioids may not 
provide adequate blockade in spinal nociceptive neurons to prevent 
generation of central sensitization (30). In general anaesthesia, when the 
patients are unconscious during surgery, processes that leads to central 
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sensitization are not affected with routine dose of opioids, So that there is 
increased postoperative pain and increased analgesic requirements.  
AVAILABLE DRUGS: 
There are various methods and drugs available for pre-emptive analgesia. 
1. Oral and parenteral non-steroidal anti -inflammatory drugs. 
2. NMDA (N- methyl D -aspartate) receptor antagonist. 
3. Local anaesthetics. Routes: local infiltration, regional anaesthesia, 
nerve blocks and intraperitoneal instillation. 
4. Antiepileptics; Gamma amino butyric acid (GABA) analogue. 
1. NON-STEROIDAL ANTIINFLAMMATORY DRUGS. 
 These drugs have analgesic and antipyretic effect. It acts by 
inhibiting cyclooxygenase enzymes. This enzyme is involved in 
formation of inflammatory messenger molecules (prostaglandin and 
thromboxanes) of inflammation. It inhibits both COX1 and COX2 
enzymes reversibly and non -selectively. Pre-emptive intravenous or oral 
NSAIDS are used in many surgeries to prevent postoperative pain. Drugs 
available for use are diclofenac sodium, celecoxib, flurbiprofen, 
parecoxib, and ketorolac. As pre-emptive agents their use in clinical 
practice is limited because of their side effects like severe gastritis, 
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postoperative bleeding, and gastro-intestinal intolerance. Recently slow 
releasing NSAIDS infiltrated into gelatin hydrogel for prolonged 
postoperative pain relief is under research level.  
 
Site of action of various pre-emptive analgesic drugs 
OPIOIDS: 
 Opioids produce profound analgesic effect by acting through 
various opioid receptors in the CNS for prolonged period. Pre-emptively 
it can be used through various routes (intravenous, regional) for surgical 
and postoperative pain relief. It provides most effective pain relief for a 
long time when used in epidural or spinal analgesia. The main 
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disadvantages with opioid use are respiratory depression, sedation, 
bradycardia, and pruritus due to histamine release.  
Local anaesthetics: 
 Local anaesthetics act by inhibiting the sodium influx in voltage 
dependent sodium channels in the neuronal membrane thereby inhibiting 
generation of action potential. Local anaesthetics are used in nerve 
blocks, regional anaesthesia and wound infiltration with or without opioid 
for surgery. In general anaesthesia local anaesthetics can be used as pre-
emptive agent through various routes. Pre-emptive administration of local 
anaesthetics at the incision site and itraperitoneally will reduce 
postoperative pain effectively equivalent to postoperative administration. 
One study showed pre-emptive epidural analgesia is somewhat effective 
in controlling intraoperative immune function, and preventing 
postoperative pain.  
Systemic antiepileptics: 
 Gabapentin and its precursor Pregabalin are most effective in 
controlling chronic neuropathic pain. Pregabalin gets absorbed rapidly 
and attains peak plasma concentration in 1 hour time. Pregabalin does not 
get metabolised by liver and 98% of the drug is excreted in urine in 
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unchanged form. Perioperative pain causes peripheral sensitization and 
central sensitization. Pregabalin and gabapentin prevent only central 
sensitization, they are not involved in preventing primary sensitization. 
Both these drugs decrease tissue damage inducing hypersensitisation of 
dorsal horn of spinal cord. They prevent secondary hypersensitisation 
effect thereby being useful in pre-emptive analgesia. Their anxiolytic 
effect is an added advantage. Both the drugs act by binding with alpha 2 
delta subunits of voltage sensitive calcium channels and preventing 
calcium influx. Pregabalin has six times more affinity to alpha 2 subunits 
than gabapentin. Pregabalin causes fewer side effects as compared to the 
gabapentin. Pregabalin and gabapentin have shown that they are useful in 
reducing the opioid consumption and its side effects, postoperative pain 
intensity.  
NMDA RECEPTOR ANTAGONIST: 
 These receptors are more abundantly present in dorsal horn of 
spinal cord and are involved in transmitting the nociceptive impulses 
from afferent fibers, to the higher centre. Blockade of these receptors 
leads to prevention of central sensitisation and postoperative pain. Drugs 
available for pre-emptive analgesia are ketamine, dextromethorphan and 
flupirtine. Some studies showed that pre-emptive ketamine alone did not 
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provide adequate analgesia, but when combined with NSAID, it provided 
effective analgesia in the postoperative period. The disadvantages with 
ketamine use are delirium, increased oral secretion, and increased 
pressures in the body. Flupirtine is indirectly acting NMDA receptor 
antagonist. It is devoid of side effects caused by ketamine, NSAID and 
opioid. These advantages and analgesic potential of flupirtine are the 
factors which prompted and interested me to do this study.  
EFFECTS OF POSTOPERATIVE PAIN: 
 Intense postoperative pain may cause many detrimental acute and 
chronic effects. Decreased noxious input to the central nervous system 
and adequate perioperative analgesia can avoid complications and 
improve immediate postoperative recovery.  
ACUTE EFFECTS: 
 Nociceptive stimuli transmission from peripheral to central nervous 
system results in neuroendocrine stress response. The predominant 
neuroendocrine response to the pain involves hypothalamic-pituitary-
adrenocortical and sympatho - adrenal interactions. Uncontrolled pain 
results in increased sympathetic tone, increased catabolic hormone, 
catecholamine hormone (cortisol, ADH, ACTH, aldosterone, glucagon) 
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secretion and decreased anabolic hormone secretion through supra 
segmental reflex. These effects lead to following changes. 
 Retention of sodium and water. 
 Increased blood glucose level 
 Increased free fatty acids and ketone bodies level 
 Increased lactate level. 
 Oxygen consumption and metabolism are increased  
 Substrates for metabolism are moved from storage depot. 
 Protein catabolism and negative nitrogen balance  
 This neuroendocrine stress response is likely to cause 
hypercoagulable state in the postoperative period. Coagulation 
enhancement (due to decreased anticoagulants level and increased 
procoagulants levels), fibrinolysis inhibition, increased plasma viscosity 
and increased platelet activity may increase the incidence of deep vein 
thrombosis, myocardial ischemia and vascular graft rejection.  
 The stress response may increases immunosuppression. This 
immunosuppression correlates with extent of surgical trauma. 
Hyperglycaemia due to stress response may cause poor wound healing 
and immune function. 
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 Increased sympathetic activation due to pain may increase 
myocardial oxygen consumption. It may decrease oxygen supply to the 
myocardium by causing vasoconstriction. It may attenuate the local 
metabolic vasodilation. Increased sympathetic activation may delay the 
gastrointestinal motility that leads to paralytic ileus.  
 Activated nociceptors may cause detrimental effect in spinal arc 
reflexes. Decreased pulmonary functions are due to spinal reflex 
inhibition of phrenic nerve. Patients with uncontrolled postoperative pain 
may cough inadequately and breathe less deeply. All these factors lead to 
pulmonary complications.  
CHRONIC EFFECTS: 
 10 to 65% of postoperative patients are suffering from chronic 
postsurgical pain (CPSP), of these 2 to 10% of patients experience severe 
chronic postsurgical pain. Inadequately controlled acute postoperative 
pain is an important factor in the formation of chronic postsurgical pain. 
Chronic postsurgical pain is common in thoracotomy, sternotomy, limb 
amputation, and breast surgery and cholecystectomy procedures. Causal 
relationship has not been definitively established, and various factors 
(e.g., area of postoperative hyperalgesia) may be more significant in 
predicting the formation of CPSP. Patients with intense preoperative pain 
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level may develop central censitisation that leads to higher postoperative 
pain and development of chronic pain. Control of acute postoperative 
pain can improve long-term recovery or patient-reported outcomes. 
Postoperative chronic pain that develops due to poor postoperative pain 
control may interfere with patient’s activities of daily living.  
PROBLEMS ASOCIATED WITH ABDOMINAL SURGERY: 
 After abdominal surgeries especially upper abdominal surgeries, 
pulmonary function is affected. If postoperative analgesia is not adequate, 
patients will hypoventilate due to pain. This leads to hypoxia, hypercarbia 
and retained secretions etc. Adequate postoperative pain management 
improves the effectiveness and pattern of ventilation. Drugs such as 
opioids will cause respiratory depression and sedation, which should be 
avoided to prevent pulmonary complications. Hypothermia caused by 
heat loss through radiation, conduction and convection in abdominal 
surgeries, leads to organ perfusion dysfunction and metabolic acidosis. 
Hypothermia should be avoided by using warm fluid, heated mattresses, 
optimising the operating room temperature and fully covering the 
exposed area. Humidifier should be placed in anaesthesia circuit for 
prolonged surgery. Closed circuit with low flow is recommended. 
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 Most of the time in abdominal surgeries, there will be major fluid 
shifts, according to the disease pattern. This fluid loss should be corrected 
before the procedure. Hypercoagulability is common with stomach, colon 
and pancreatic cancer. Previous chemotherapy causes anaemia, 
cardiomyopathy, renal and liver toxicity. Patients on opioid for cancer 
pain for prolonged period require increased dose of opioids for 
postoperative pain management.  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
PHARMACOLOGY 
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PHARMACOLGY 
HISTORY: 
 Flupirtine has been used for treatment of pain arising from surgery, 
trauma, tooth extraction, dysmenorrhea, migraine, joint diseases, muscle 
spasm and cancer for past 25 years in Europe. A German pharmacist 
named Homburge first synthesized flupirtine in 1981. In Europe 
Flupirtine was approved for management of pain in 1984. In India 
flupirtine is available in various brand names. In 2010 Retigabine 
chemically related to flupirtine was approved for management of partial 
seizure. 
CHEMICAL STRUCTURE: 
 Flupirtine is derived from triaminopyridine compound. It has a 
chemical structure “2-amino-3-ethoxy-carbonylamino-6-4-
fluorobenzylamino-Pyridine”. The basic molecule required for synthesis 
of flupirtine is “2, 6-dichoro 3-nitropyridine”. Flupirtine synthesis is a 4 
steps process starting from this basic molecule. Flupirtine’s chemical 
formula is C15H17FN4O2. Its molecular weight is 304.32g/mol.  
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Chemical structure 
MECHANISM OF ANALGESIC ACTION: 
 
 Flupirtine is indirectly acting NMDA (N-methyl-D-aspartate) 
receptor antagonist by opening the K+ channels. Flupirtine antagonises 
NMDA receptor induced glutamate mediated increase in intracellular 
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calcium ion concentration in dose dependent manner. Flupirtine binds 
with G protein coupled receptor in neuronal cell membrane and activates 
the K+ channels. This activation of K+ channels leads to increase in 
intracellular K+ ion concentration, then hyperpolarisation of neuronal cell 
membrane. These neuronal cells become less excited. The drugs opening 
these neuronal K+ channels are called as “selective neuronal potassium 
channel openers” (SNEPCO)(31). Flupirtine is prototype of SNEPCO. This 
opening of K+ channels indirectly suppresses the NMDA receptor 
activation. This action blocks the transmission of nociceptive impulses. 
Muscle relaxant action: 
 Inhibition of mono and poly synaptic reflexes causes muscle 
relaxation. NMDA receptor mediates the spinal polysynaptic reflexes. 
Monosynaptic reflexes are mediated by non NMDA receptors. Flupirtine 
blocks NMDA receptor mediated poly synaptic reflexes leading to 
muscle relaxation. Flupirtine causes analgesia and muscle relaxation, in 
same dose range. This muscle relaxing property of flupirtine necessitates 
its use in muscle spasticity and chronic musculoskeletal pain(32). 
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Neuro-protective action: 
           Apoptosis of neuronal cells are caused by increased intracellular 
calcium ions, nucleolysis, and membrane disruption. Flupirtine protects 
the neuronal cells from apoptosis, by suppressing the NMDA receptor 
mediated rise in intracellular Ca2+ ions. In vitro studies showed that 
flupirtine increases Bcl 2 ( antiapototic gene ) and glutathione levels in 
cultured retinal pigment cells. It also decreases expression of oncogenes 
and production of oxygen reactive radicals in cell cultures(33). 
Antiparkinsonian action: 
 Flupirtine decreases muscle rigidity and increases the L- DOPA 
ability to reverse the akinesia. Flupirtine has potent anticataleptic activity. 
Flupirtine alone or combined with L-DOPA can be used for haloperidol 
induced cataleptic activity(34). 
PHARMACOKINETICS: 
Absorption: 
 Flupirtine is hydrophilic in nature. This water soluble compound is 
completely absorbed from gastrointestinal tract. When administered 
through oral route the bioavailability is 90%. For rectal route it is about 
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70%. In healthy individuals 100 mg of oral flupirtine reaches peak plasma 
concentration (773mcg/l) at 1.6 hours. 
Distribution: 
 Flupirtine has large volume of distribution. It is equally distributed 
in intra vascular and extravascular compartments. 80 – 84% of flupirtine 
is bound to albumin. The drug concentration in plasma and CSF is same. 
Higher concentration is seen in liver and exocrine glands. Lower 
concentration is seen in kidney. T1/2 of 100mg oral flupirtine is 6.5 
hours. For intravenous and rectal route it is 8.5 and 10.7 hours 
respectively. The clearance rate for oral route is 275ml/min. The 
clearance rate is decreased in elderly and renal impairment patients. 
Metabolism and elimination: 
 Flupirtine is metabolised by peroxidase enzymes in liver and forms 
inactive metabolites. The metabolites are 4-Fluorohippuric and N-
acetylated analogue D13223. These metabolites have 20-30% of parent 
drug activity. These metabolites are oxidised further and conjugated with 
glycine to form inactive metabolites. 72% of the administered drug is 
excreted in urine as parent compound and its metabolites. 18% of the 
drug is excreted in feces(35). 
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Dosage and formulation: 
 Flupirtine can be given through oral and rectal routes. Flupirtine 
50mg and 100mg is available for oral administration. Adult dose is 
300mg - 400mg / day in 3 - 4 divided doses with maximum dose of 
600mg per day(36). For rectal administration the dose range is 450-600mg 
in divided doses. 
Drug interaction: 
 Flupirtine increases warfarin toxicity when both the drugs are 
administered together. The toxicity mechanism is not clear. Prothrombin 
time should be monitored in patients on warfarin therapy. Flupirtine 
increases paracetamol induced hepatotoxicity. When both the drugs are 
used together, liver enzymes monitoring is essential. Alcohol may 
potentiate dizziness and tiredness, due to flupirtine. Carbamazepine 
increases flupirtine metabolism by inducing liver enzymes. 
Contraindications: 
 Safety of Flupirtine use in pregnancy, breast feeding women and 
children < 6 years is not clear. 
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Flupirtine should be avoided in following conditions: 
 Hypersensitivity to flupirtine 
 Hepatic encephalopathy 
 Chronic alcoholism 
 Myasthenia gravis 
 Cholestasis 
 Primary biliary cirrhosis. 
USES: 
1. Flupirtine is most effective in relieving acute and chronic pain like 
trauma, migraine, tension headache(37). 
2. Due to its muscle relaxing property, It is most useful in backache and 
orthopaedic pain  
3. Due to its neuroprotective action flupirtine can be used in Alzheimer’s 
disease and Multiple sclerosis. 
4. It is most effective in reducing the intensity of cancer(38) and 
postoperative pain(39). 
5. In Parkinson’s disease flupirtine is used as an anticataleptic agent, it 
also relaxes muscle rigidity. 
6. Flupirtine has advantage over opioid and NSAID, since it does not 
cause any gastritis, respiratory depression and dependence. 
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SIDE EFFECTS: 
 Flupirtine is a safe drug. It has better tolerability. Flupirtine side 
effects are dose dependent. 
CNS Side Effects: 
 On long term uses flupirtine causes the following CNS side effects 
in few patients’ dizziness, depression, sedation, headache, weakness, 
disorientation. 
Peripheral Side Effects: 
 Nausea, vomiting, mouth dryness, constipation, heart burn 
abdominal discomfort, pruritus, elevated liver enzymes and sometimes 
arrhythmia. 
 
 
 
 
 
  
 
 
 
 
 
MATERIALS AND 
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MATERIALS AND METHODS 
STUDY CENTER:  
 Department of Anaesthesiology, ESIC MEDICAL COLLEGE & 
PGIMSR, K.K.nagar, Chennai. 
STUDY DESIGN:  
 Prospective randomized controlled study. 
STUDY PERIOD:  
 June 2015 to June 2016 
Participants  
 Patients scheduled for abdominal surgery were included in this 
study. The study was approved by ESIC MC & PGIMSR institutional 
ethical committee, K.K.nagar. After getting departmental approval and 
informed written consent was obtained from study patients before the 
study was started. 
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Inclusion criteria: 
1. Patients aged between 18 -60 years of either sex with weight 50 to 
90kg  
2. American society of Anaesthesiologist physical status I and II  
3. Patient scheduled for elective abdominal surgeries. 
Exclusion criteria: 
1. Consent not given 
2. History of drug allergy  
3. Chronic alcoholism 
4. History of psychiatric disorder 
5. History of analgesic or opioid usage within one month 
6. Pregnancy 
7. Liver and renal dysfunction 
Sample size justification (nMaster 2.0 software): 
 Sample size was calculated based on clinical trials-parallel design –
hypothesis equivalence /bioequivalence. 
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Test available 
Difference in means-equal 
allocation 
Equivalence margin 9 
Observed/expected difference 5.17 
Standard deviation 5.55 
Effect size  0.690090 
Power (1-β) 80% 
Alpha error 5% 
Required sample for first group 26 
Required sample for second group 26 
 
 Taking dropouts into consideration the sample size in each group 
was chosen as 30 patients. 
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BASELINE EVALUATION: 
Previous day of surgery basic evaluation was done, which included 
1. Detailed history  
2. Weight, height and body mass index recorded 
3. General and airway examination  
4. Systemic examination was done  
5. Baseline vitals such as pulse rate, blood pressure, oxygen 
saturation were recorded 
LABORATORY INVESTIGATION: 
The routine biochemical investigations were carried out in all patients.  
1. Complete blood count. 
2. Blood sugar from random sample  
3. Urea and creatinine 
4. Liver function test 
5. Chest radiography PA view 
6. Electrocardiography. 
All patients were nil per oral for 8 hours before the procedure.  
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 Aspiration prophylaxis was followed with Injection ranitidine 
50mg IV plus Injection metaclopromide 10mg IM in all patients. 
RANDOMISATION: 
60 patients posted for abdominal surgeries under general anaesthesia 
were divided into two groups by slips in box technique 
  
 
 
 
 
30 patients in each group 
 When patients arrived in the preanaesthetic room all patients were 
explained about interpretation of numerical rating scale to assess the 
postoperative pain intensity. 
 18 gauge venflon was started, A maintenance fluid RINGER 
LACTATE/NORMAL SALINE at 100 ml /hr. was given. 
GROUP A 
ORAL PLACEBO GIVEN 
2 HOURS BEFORE THE 
SURGERY 
GROUP B 
ORAL FLUPIRTINE 200mg 
GIVEN 2 HOURS BEFORE 
THE SURGERY 
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INTERVENTION: 
 In the preanesthetic room patients in GROUP A received 2 placebo 
capsules resembling flupirtine 2 hours before surgery. 
 Patients in GROUP B received 2 capsules of 100mg flupirtine 2 
hours before surgery.  
 Both groups of patients were monitored with pulse oximetry for 
pulse rate and oxygen saturation until being shifted to operating room. 
Pulse rate and oxygen saturation were recorded at 15 minutes interval for 
2 hours.  
 Patients were shifted to operating room in a trolley by trained 
technician.  
TECHNIQUE: 
 In the operating room following monitors were attached  
1. Pulse oximetry 
2. Non-invasive blood pressure (NIBP) 
3. Electrocardiography 
4. Capnography 
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 Baseline pulse rate, blood pressure and oxygen saturation were 
recorded. 
 The premedication, injection Glycopyrolate 5mcg /kg iv and 
injection midazolam 0.03mg /kg were given intravenously. 
 Patients were preoxygenated with 6l/min of 100% o2 through 
facemak for 5mins. 
 Patients were induced by injection propofol 2mg /kg IV and 
injection fentanyl 2mcg /kg IV. 
 Intubation was facilitated with injection vecuronium 0.01mg/kg iv 
then using direct laryngoscopy endotracheal intubation was done. 
 Anaesthesia was maintained by oxygen and nitrous oxide in a 
concentration of (50%:50%) ratio and sevoflurane 1%. 
 Injection vecuronium 0.02mg kg/iv was repeated as patient 
recovered from relaxant.  
 Injection fentanyl 25 mcg IV was given if baseline blood pressure 
increased above 20%.  
 After the procedure was completed, residual paralysis was reversed 
with injection neostigmine 0.05mg/kg and injection glycopyrolate 
0.01mg /kg IV. 
 After achieving adequate recovery, patient was extubated and 
shifted to post anaesthesia care unit (PACU).  
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 In PACU, patients were monitored for postoperative pain using 
numerical rating scale and sedation was assessed by using Ramsey 
sedation score. 
NUMERICAL RATING SCALE: 
 Postoperative pain was assessed by using 10 point numerical rating 
scale. This measurement is carried out with a 10 cm line. One end 
denotes 0, it means no pain. Another end denotes with 10, it means severe 
pain. Patients were asked to touch between these two points to reveal 
their severity of pain. 
 
 Numerical rating scale score was recorded every 1 hour for first 6 
hours thereafter every 2 hours until 16 hours, then at 4 hours interval for 
24 hours. 
 
 
NRS 
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 If numerical rating scale core was ≥4, the rescue analgesic injection 
tramadol 50mg was given intravenously at 4 hours interval.  
The time to first rescue analgesic requirement was noted.  
Ramsey Sedation Scale: 
 The postoperative sedation was assessed using Ramsey sedation 
score(40). It was also recorded in a same interval as recorded in numerical 
rating scale. 
Ramsey sedation score 1: 
 Anxious, agitated, restless 
Ramsey sedation score 2: 
 Cooperative, Oriented, tranquil, 
Ramsey sedation score 3: 
 Responsive to commands only  
Ramsey sedation score 4: 
 Brisk response to light glabellar tap or loud auditory stimulus 
Ramsey sedation score 5: 
 Sluggish response to light glabellar tap or loud auditory stimulus 
Ramsey sedation score 6: 
 No response to light glabellar tap or loud auditory stimulus 
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PATIENT FLOW CHART 
ASSESSMENT CLINIC 
  
  
In the preoperative ward- randomisation (slips in the box) 
  
 
Patient shifted to the operation theatre by trained personnel in a trolley 
Inside theatre - monitors connected, i.v. Line secured 
Preoxygenation with 100% O2 for 5mins 
 Induction with Inj. Propofol 2mg/kg, Inj. Fentanyl 2μg/kg  
 Intubation with Inj. Vecuronium 0.01mg/kg 
 Maintanence with O2: N2O – 50: 50%,  
Sevoflurane 1%, inj. vecuronium 0.02mg/kg and inj. fentanyl 25μg as 
and when required 
Reversal with inj.neostigmine 0.05mg/kg + ing.glyco 0.01mg/kg and 
extubation 
POST OPERATIVE PERIOD  
1. Time for first Rescue Analgesic 
2. Severity of Post-Operative Pain assessed in terms of NRS 
3. Postoperative sedation assessed using Ramsey Sedation Scale  
GROUP A 
ORAL PLACEBO Cap. 
GIVEN 2 HOURS 
BEFORE THE SURGERY 
GROUP B 
ORAL FLUPIRTINE 
200mg GIVEN 2 HOURS 
BEFORE THE SURGERY 
ASAI and ASAII (18-60 
years of either sex) 
Informed consent 
Numerical rating scale 
explained 
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STATISTICAL ANALYSIS AND RESULTS 
 The data was analysed using IBM SPSS (Statistical Package for 
Social Science) software Version 21. The data collected were scored and 
analysed, continuous variables were presented as means with Standard 
deviation (sd). Categorical variables were presented as frequency and 
percentages. Student t-test was used for testing the significance of all the 
variables mean and standard deviation in groups. Chi-square test was 
used to compare proportions. All the statistical results were considered 
significant at P value ≤ 0.05. 
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Table-1 
GENDER DISTRIBUTION  
 GROUP-A GROUP-B TOTAL 
N % N % N % 
MALE 17 56.67 15 50.00 32 53.33 
FEMALE 13 43.33 15 50.00 28 46.67 
TOTAL 30 100 30 100 60 100 
Chi-square 
value 
0.27 
p-value 0.61 
Significant  Not Significant 
 N-Number of patients.    %- percentage 
 
        GROUP A and GROUP B are comparable in respect to gender 
distribution. Male and females are equally distributed in both groups and 
statistically insignificant (p=0.61) 
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Table-2 
AGE DISTRIBUTION 
Age 
(in years) 
GROUP-A GROUP-B 
N % N % 
≤ 19 2  6.67 2  6.67 
20 - 30 3 10.00 6 20.00 
30 - 40 8 26.66 11 36.67 
40 - 50 17 56.67 6 20.00 
50 - 60 0 0 5 16.67 
TOTAL 30 100 30 100 
Mean ± SD 38.93 ± 8.87 38.47 ± 11.54 
t-value 0.18 
df 58 
p-value 0.86 (Not Significant) 
 
 
 Maximum age in both groups is between 31 - 40 years of age. Age 
is comparable in both groups with p value of 0.86. 
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Table-3 
 WEIGHT 
WEIGHT IN KGS 
GROUP-A GROUP-B t-value df p-value 
MEAN SD MEAN SD 
66.83 8.30 64.07 9.11 1.23 0.22 0.15 
(Not 
Significant) 
 
 
 In respect to weight group A group B were comparable with each 
other (p=0.15) 
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Table-4 
HEIGHT DISTRIBUTION 
HEIGHT IN CM 
GROUP-A GROUP-B t-value df p-value 
MEAN SD MEAN SD 
158.27 8.77 156.13 7.18 1.03 58 0.31 
(Not 
Significant) 
 
                                                           HEIGHT  
 
Both groups are comparable in view of height (p=0.31) 
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 With respect to American society of anaesthesiologist physical 
status both groups are comparable. In both groups maximum number of 
ASA I patients were included in this study. 
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Table-5 
TYPE OF SURGERY  
SURGERY 
GROUP-A GROUP-B 
No of 
patients % 
No of 
patients % 
INCISIONAL HERNIA 20 66.67 19 63.34 
PARA UMBILICAL HERNIA 5 16.67 6 20.00 
APPENDECTOMY 4 13.33 4 13.33 
OPEN 
CHOLECYSTECTOMY 
1  3.33 1  3.33 
TOTAL 30 100 30 100 
Chi-square  0.12 
df 3 
p-value  0.99 ( Not Significant ) 
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 The types of surgery performed in both groups were equally 
distributed in group A and group B. The most common surgery 
performed in both groups was incisional hernia repair under general 
anaesthesia. 
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Table-6 
Pulse rate after drug (placebo/flupirtine) administration: 
PR 
TIME 
GROUP-I GROUP-II 
t-value df p-value 
MEAN SD MEAN SD 
15 Min 75.07 7.78 78.63 9.86 1.56 58 0.13 
30 Min 75.07 6.98 77.73 10.97 1.12 58 2.27 
45 Min 75.20 7.45 76.77 11.92 0.61 58 0.54 
 1 Hour 75.33 8.03 76.17 11.34 0.33 58 0.74 
1.15 Hr 74.67 7.82 74.77 10.80 0.04 58 0.97 
1.30 Hr 75.03 7.92 74.73 10.24 0.13 58 0.90 
1.45 Hr 74.23 7.58 74.97 10.96 0.30 58 0.76 
2.00 Hr 73.67 6.94 74.37 10.34 0.31 58 0.76 
 
 Pulse rate and oxygen saturation were not significantly changed 
after giving the study drugs. The mean value of pulse rate after drug 
administration was graphed in a line diagram. The trends for mean value 
pulse rate for both groups are same. No significant change in the pulse 
rate after drug administration. 
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 The mean values of pulse rate, systolic blood pressure, diastolic 
blood pressure plotted as trend in the line diagram were lesser in 
flupirtine group compare to control group, even though not significant. 
Table-7 
DURATION OF SURGERY (in Minutes) 
Group  Mean Sd Minimum Maximum 
GROUP-A 123.67 25.22 75 150 
GROUP-B 121.17 26.38 60 150 
t-value 0.38 
p-value 0.71 
Significant Not Significant 
 
 Both groups were comparable in duration of surgery. It was 
statistically not significant (p=0.71). The mean duration of surgery in 
group A and group B was 123.67 mins and 121.17 mins respectively. 
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Table -8 
NUMERICAL RATING SCALE 
TIME 
(In 
postoperative 
Period) 
GROUP-A GROUP-B 
t-
value 
df 
p-
value MEAN SD MEAN SD 
1 Hour 4.07 1.80 2.00 1.15 5.31 58 0.000* 
2 Hour 4.47 1.04 2.97 1.59 4.33 58 0.000* 
3 Hour 4.23 0.90 3.83 1.39 1.32 58 0.19 
4 Hour 4.03 0.85 4.13 1.17 0.38 58 0.71 
5 Hour 4.07 0.94 4.43 1.36 1.22 58 0.23 
6 Hour 4.23 1.19 4.10 1.56 0.37 58 0.71 
8 Hour 3.77 0.90 3.77 0.90 0.11 58 0.92 
10 Hour 3.37 0.96 3.47 1.43 0.32 58 0.75 
12 Hour 3.17 1.09 3.27 1.48 0.30 58 0.77 
14 Hour 2.97 0.85 2.87 1.31 0.35 58 0.73 
16 Hour 2.77 0.73 2.37 1.03 1.73 58 0.09 
20 Hour 2.57 0.82 1.93 0.91 2.84 58 0.01* 
24 Hour 2.23 0.90 1.57 0.77 3.08 58 0.003* 
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 The mean numerical rating scale scores were initially lower in 
GROUP B patients than GROUP A for first 3 hours. Of these, first 2 
hours of postoperative analgesia were statistically significant. The mean 
value of NRS score in group B was initially less than three for first 3 
hours. Higher values were noted between 4-6th hour of postoperative 
period.  
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Table-9 
TIME TO RESCUE ANALGESIA 
TIME 
GROUP-A GROUP-B 
N % N % 
FIRST HOUR 18 60.00  1  3.33 
SECOND HOUR  8 26.67  4 13.33 
THIRD HOUR  4 13.33 14 46.67 
FOURTH HOUR  0 -  5 16.67 
FIFTH HOUR  0 -  6 20.00 
TOTAL 30 100 30 100 
Chi-square  33.10 
df 4 
p-value 0.000 ( Significant ) 
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60% of the patients in control group asked rescue analgesia in first
hour of postoperative period. But only 3.3% of the patients in flupirtine
group asked rescue analgesia in the first hour of postoperative period.
82% (46% in 3rd hour, 16% in 4th hour, and 20% in 5th hour) of the
patients in flupirtine group required recue analgesia after 3rd hour of
postoperative period. This difference was significant (p=0.00).
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Table-10 
RAMSEY SEDATION SCALE  
TIME 
(Hours) 
GROUP-A GROUP-B 
t- value P-value Significant 
Mean Sd Mean Sd 
1 1.93 1.36 3.57 0.86 5.55 0.000 Significant 
2 1.67 0.99 2.93 0.74 5.60 0.000 Significant 
3 1.37 0.49 2.33 0.84 5.42 0.000 Significant 
4 1.63 0.56 2.17 0.87 2.82 0.01 Significant 
5 1.63 0.56 2.00 0.74 2.16 0.04 Significant 
6 1.80 0.71 1.87 0.57 0.52 0.61 NS 
8 1.67 0.55 1.80 0.61 0.89 0.38 NS 
10 1.70 0.60 1.70 0.47 0.01 1.00 NS 
12 1.73 0.5 1.53 0.51 1.51 0.14 NS 
14 1.67 0.48 1.47 0.63 1.39 0.17 NS 
16 1.77 0.50 1.43 0.57 2.40 0.02 Significant 
20 1.73 0.52 1.30 0.47 3.40 0.001 Significant 
24 1.70 0.47 1.17 0.38 4.86 0.000  Significant 
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 There was statistically significant change noted in Ramsey sedation 
score (RSS) for first 5 hours of postoperative period. The patients in 
flupirtine group exhibited more sedation, but remained responsive to 
commands. 
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Table-11 
SIDE EFFECTS 
SIDE EFFECTS 
GROUP-A GROUP-B 
No of 
Patients 
% 
No of 
Patients 
% 
NIL 29 96.67 23 76.67 
BRADYCARDIA 0 0 1 3.33 
RETROSTERNAL 
DISCOMFORT  
0 0 1 3.33 
NAUSEA  0 0 2 6.67 
VOMITING  1  3.33 1 3.33 
GIDDINESS  0 0 2 6.67 
TOTAL 30 100 30 100 
Chi-square  6.69 
df 5 
p-value 0.25 ( Not Significant ) 
 
 Seven patients in group B experienced side effects like 
bradycardia, retrosternal chest discomfort, nausea, vomiting and 
giddiness. Only one patient in group A experienced vomiting.  
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DISCUSSION 
 Pre-emptive analgesic modalities can be used as singly or in 
combination. Many studies have been done to evaluate the pre-emptive 
analgesic effect of opioid and NSAIDs. Cliff K.-S. Ong et al(41) 
performed a meta-analysis and demonstrated that ability of pre-emptive 
analgesic interventions to decrease the postoperative pain scores, prolong 
the time to first rescue analgesia and decrease postoperative opioid 
requirement. Using these measures pre-emptive analgesia showed 
beneficial effect after epidural analgesia, local infiltration, and NSAIDs 
drug administration. Pre-incisional analgesic drug administration showed 
more effectiveness in decrease the postoperative pain by protecting the 
CNS from noxious stimuli induced deleterious effect, and which may 
lead to increased pain and hyperalgesia.  
 Flupirtine is an indirectly acting NMDA receptor antagonist. It has 
beneficial effect in controlling acute and chronic pain like trauma, 
migraine, cancer pain and low backache. Its muscle relaxant and neuro-
protective effect is an additional beneficial effect.  
 In this study group A and group B patients were comparable with 
respect to gender distribution, age, weight, height, ASA physical status, 
types of surgery performed and duration of surgery. Flupirtine attained 
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the peak plasma concentration in about 1.6 to 2 hours when given through 
oral route. Many studies showed that flupirtine analgesic effect was dose 
dependent. Previous studies done with 200mg flupirtine revealed 
effective analgesia in controlling postoperative pain in their studies. 
Further increase of flupirtine dose may lead to side effects like sedation, 
giddiness, drowsiness in the postoperative period so we chose 200mg of 
oral flupirtine to achieve effective analgesia with fewer side effects.  
 In this study pre-emptively given oral flupirtine 200mg provides 
effective analgesia for first 2 to 3 hours of postoperative period. Of these 
first 2 hours of postoperative analgesia were statistically significant 
(p=0.00, p=0.00). There after patient experienced only mild pain for 
entire postoperative period. This is most convincingly shown by the 
numerical rating scale score as it was initially low in the first 3 hours of 
postoperative period. After that the numerical rating scale score, has 
shown lower values in the study group than control group for the 
remaining postoperative period. Patients were followed up for 24 hours 
postoperatively. S.M Abrams(42) et all stated that, flupirtine when given 
orally, it attained peak plasma concentration at 1.5 to 2 hours and the 
analgesic effects lasted for 6.5 to 8 hours. Hence it is assumed that, in our 
study flupirtine attained peak plasma concentration during intraoperative 
period and provided adequate analgesia during that period. This was 
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indicated by stable vitals which were noted, till the early postoperative 
period. But there was no much statistically significant difference noted in 
the late postoperative period. The time to rescue analgesia was longer in 
duration in group B patients (p=0.00). It was comparable to studies done 
by vanitha ahuja and ambarish sharma. Vanitha ahuja et al conducted a 
study to compare the pre-emptive analgesic effect of 100 mg of flupirtine 
with ibuprofen in gynaecological ambulatory surgeries. Their study 
showed VNRS score was lower in 2nd hour of postoperative period in 
flupirtine groups. Ambrish Sharma et al conducted a study to compare 
the analgesic effect of flupirtine with piroxicam in low backache patients. 
Their study revealed flupirtine has analgesic effect similar to the 
piroxicam with better tolerability. 
 In this study Ramsey sedation score was statistically significant in 
the first 5 hours of postoperative period (p-0.00, p=0.00, p=0.00, p=0.01 
and p=0.04). The mean values of RSS for first five hours in group B 
patients were 3.57, 2.93, 2.33, 2.17 and 2.0 respectively. The mean value 
of RSS in group A patients were 1.93, 1.67, 1.37, 1.63 and 1.63 
respectively. Patients in group B experienced mild to moderate sedation 
in the first 3 hours of postoperative period. Ghanshyam yadav et al 
conducted a study to assess the pre-emptive analgesic effect of flupirtine 
in patients undergoing laproscopic cholecystectomy. They showed that 
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flupirtine effectively controlled postoperative pain in first 4 hours of 
postoperative period, with higher sedation in flupirtine groups. Yadav et 
al did a study in postcraniotomy patients to compare the analgesic effect 
of flupirtine with diclofenac sodium. Their study showed flupirtine 
provided analgesia equivalent to that of diclofenac sodium, with moderate 
sedation. But in our study, patients in study group experienced mild to 
moderate sedation in first 3 hours of postoperative period. In the entire 
study period, all patients in group A and group B maintained oxygen 
saturation above 96%. There was no incidence of hypoxia noted in the 
study period.  
 Even though the side effects were not statistically significant in this 
study, 23.3% of group B patients experienced few side effects which 
include nausea, giddiness, vomiting, retrosternal discomfort and 
bradycardia. Of these nausea and giddiness were frequently experienced. 
In contrast, only one patient had vomiting in control group. 
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CONCLUSION 
 This study concludes that pre-emptive administration of oral 
flupirtine 200mg provides effective analgesia in the first 2 to 3 hours of 
postoperative period in patients undergoing abdominal surgeries with 
mild to moderate sedation.  
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ANNEXURE 
PROFORMA 
Name of the patient:  
 Age: 
 Sex:  Wt: Ht: 
Insurance No:  OT:   
Diagnosis:    
Duration of Procedure: 
Surgeon:   Anaesthetist:  
PREOPERATIVE DETAILS 
Hb:    RBS:    RFT:    LFT:    ECG:               XRAY CHEST: 
Others:  
GROUP A/B 
Time of drug administration (placebo/flupirtine): 
Time 15 
Mins 
30 
Mins 
45 
Mins 
1 
Hour 
1HR 
15 
Mins 
1HR 
30 
Mins 
1HR 
45 
Mins 
2 
Hour 
PR         
SPO2         
 
TIME 2 
s 
2 
Min 
4 
min 
6 
min 
8 
min 
10 
min 
15 
min 
20 
min 
25 
min 
30 
min 
40 
min 
50 
min 
1 
hr 
2 
hr 
3 
hr 
4 
hr 
5 
hr 
6 
hr 
8 
hr 
10 
hr 
12 
hr 
14 
hr 
16 
hr 
18 
hr 
20 
hr 
22 
hr 
24 
hr 
PR(/MIN)                            
SBP(mm 
Hg) 
                           
DBP(mm 
Hg) 
                           
sPO2(%)                            
 
Duration of surgery:   
 
TIME               
VAS               
RSS               
TIME FOR FIRST RESCUE ANALGESIA: 
SIDE EFFECTS:  
PATIENT CONSENT FORM 
Study title:  
A PROSPECTIVE RANDOMISED CONTROLLED STUDY OF ORAL 
FLUPIRTINE AS PRE-EMPTIVE ANALGESIA IN PATIENTS 
UNDERGOING ABDOMINAL SURGERIES UNDER GENERAL 
ANAESTHESIA  
Study center:  
ESIC MEDICAL COLLEGE & PGIMSR, K.K.NAGAR, CHENNAI -78 
Participant name:      Age:  
Sex:  
I confirm that I have understood the purpose of procedure for the 
above study. I have the opportunity to ask the question and all my 
questions and doubts have been answered to my satisfaction. 
I have been explained about the pitfall in the procedure. I have 
been explained about the safety, advantage and disadvantage of the 
technique. I understand that my participation in the study is voluntary and 
that I am free to withdraw at any time without giving any reason. 
 I understand that investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both 
in respect to current study and any further research that may be conducted 
in relation to it, even if I withdraw from the study. I understand that my 
identity will not be revealed in any information released to third parties or 
published, unless as required under the law. I agree not to restrict the use 
of any data or results that arise from the study.  
I have been explained that the anesthetic technique is a standard 
and approved technique. This may help in future research in the field of 
anesthesia. I consent to undergo this procedure 
Insurance No:  
 Date: Signature / thumb impression of patient: 
 
 
 
 
 
 
  
 
 
 
 
 
KEY TO MASTER CHART 
GROUPS: 
GROUP A – PLACEBO DRUG 
GROUP B- FLUPIRTINE GROUP 
PARAMETERS: 
N - NUMBER OF PATIENTS. 
WT - WEIGHT IN KG 
HT - HEIGHT IN CENTIMETER 
ASA - AMERICAN SOCIETY OF ANAESTHESIOLOGIST 
PR -PULSE RATE 
SBP -SYSTOLIC BLOOD PRESSURE  
DBP - DIASTOLIC BLOOD PRESSURE 
SPO2 - OXYGEN SATURATION 
NRS - NUMERICAL RATING SCALE 
RSS - RAMSEY SEDATION SCORE  
NA- NAUSEA 
V- VOMITING 
G- GIDDINESS 
B- BRADYCARDIA 
RSD- RETROSTERNAL DISCOMFORT 
NAME AGE SEX WEIGHT HEIGHT GROUP ASA SURGERY SIDEEFFECTS
15 MINS 30 MINS 45 MINS 1 HR 1:15 MINS 1:30 MINS 1:45 MINS 2 HRS 1 MIN 15 MINS 30 MINS 45 MINS 1 HR 1 HR 15MINS
1 HR 30
MINS
1 HR 45
MINS 2 HRS
2 HR 15
MINS
2 HR
30
MINS
2 HR
45
MINS
3 HR 4 HR 5 HR 6 HR 7 HR 8 HR 10 HR 12 HR 14 HR 16 HR 18 HR 20 HR 24 HR PREOPSBP 1 MIN
15
MINS
30
MINS
45
MINS 1 HR
1 HR
15
MINS
1 HR
30
MINS
1 HR
45
MINS
2 HRS
2 HR
15
MINS
2 HR
30
MINS
2 HR
45
MINS
3 HR 4 HR 5 HR 6 HR 7 HR 8 HR 10 HR 12 HR 14 HR 16HR 18 HR 20 HR 24 HR
PREOP
DBP 1 MIN
15
MINS
30
MINS
45
MINS 1 HR
1 HR
15
MINS
1 HR
30
MINS
1 HR
45
MINS
2 HRS
2 HR
15
MINS
2 HR
30
MINS
2 HR
45
MINS
3 HR 4 HR 5 HR 6 HR 7 HR 8 HR 10 HR 12 HR 14HR 16 HR 18 HR 20 HR 24 HR
SPO2
(%) 1 MIN 15 MINS 30 MINS 45 MINS 1 HR
1 HR 15
MINS
1 HR 30
MINS
1 HR 45
MINS 2 HRS
2 HR 15
MINS
2 HR 30
MINS
2 HR 45
MINS 3 HR 4 HR 5 HR 6 HR 7 HR 8 HR 10 HR 12 HR 14 HR 16 HR 18 HR 20 HR 24 HR
DURATION OF
SURGERY IN
MINS
POSTOP
NRS 1
HR
2 HR 3 HR 4 HR 5 HR 6 HR 8 HR 10 HR 12 HR 14 HR 16 HR 20 HR 24 HR
POST
OP
RSS1
2
HR
3
HR 4 HR 5 HR 6 HR
8
HR
10
HR
12
HR
14
HR
16
HR 20 HR 24 HR
CHINNAPONNU 46 F 51 140 A II  INCISIONAL HERNIA 74/100 76/100% 74/100% 76/100% 74/100% 77/100% 73/100% 72/100% 78 90 96 90 84 85 86 86 84 82 81 84 83 86 85 84 83 81 79 77 74 79 77 74 74 130 140 130 141 142 130 126 128 129 126 126 126 124 140 140 139 136 139 136 134 130 129 121 129 121 124 80 90 89 101 102 101 100 89 86 89 89 84 85 90 91 90 92 90 96 90 96 84 85 86 84 85 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 97% 99% 98% 98% 99% 100% 99% 98% 98% 99% 100% 120 6 4 4 4 5 6 4 3 3 3 3 2 2 1 1 1 1 1 2 2 2 2 2 2 2 2 1 0
SIVA KUMAR 39 M 78 160 B I INCISIONAL HERNIA 78/100 78/100% 74/100% 74/100% 72/100% 73/100% 74/100% 70/100% 80 78 79 81 77 78 79 79 85 75 75 74 74 87 86 76 71 72 77 76 81 84 85 88 81 127 130 125 121 119 121 128 122 115 114 117 119 121 129 126 125 131 135 132 126 127 121 120 118 `129 120 79 81 82 81 82 84 86 84 82 83 81 79 77 76 75 79 75 76 70 79 76 85 86 83 82 82 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 99% 99% 99% 100% 99% 99% 99% 120MINS 2 3 4 5 5 6 6 3 4 3 3 3 2 3 3 3 2 2 2 1 1 2 2 2 1 1 3 0
SHEELA 36 F 70 150 B I OPENCHOLECYSTECTOMY 81/100% 84/100% 83/100% 79/100% 77/100% 76/100% 77/100% 79/100% 76 63 56 72 66 64 62 62 66 61 66 58 55 50 48 45 36 42 48 56 57 61 63 64 66 130 110 91 91 125 121 121 126 124 126 122 143 135 130 132 128 106 100 112 120 122 123 131 128 128 120 90 61 65 65 94 88 84 91 90 91 88 94 87 80 81 70 59 58 61 66 64 65 68 71 72 74 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 98% 99% 100% 100% 99% 99% 99% 98% 99% 100% 135 2 2 2 2 5 3 3 3 2 2 1 1 1 3 3 2 2 2 2 2 2 1 1 1 1 1 5 B
JAMUNA 35 F 52 153 B I INCISIONAL HERNIA 91/100% 88/100% 85/100% 84/100% 83/100% 84/100% 84/100% 86/100% 71 66 65 63 61 59 61 68 69 72 73 74 76 77 78 74 73 71 71 71 74 76 78 79 77 118 101 99 98 91 106 102 118 121 124 121 121 116 118 117 118 119 114 113 109 120 121 123 124 126 128 76 58 55 56 50 61 60 66 68 69 71 72 72 73 74 75 76 75 64 60 74 71 72 73 74 78 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 97% 97% 98% 99% 99% 98% 100% 98% 98% 99% 99% 90 2 2 2 4 6 3 3 2 2 3 3 3 1 3 3 3 2 2 1 1 1 1 1 1 1 1 5 0
REVATHI 45 F 88 164 B II INCISIONAL HERNIA 66/100% 65/100% 63/100% 66/100% 65/100% 64/100% 63/100% 65/100% 66 65 61 62 63 61 60 59 57 58 54 58 54 55 56 54 58 59 60 61 62 63 64 60 66 130 130 99 101 101 121 131 140 142 143 140 135 138 148 130 128 127 126 128 129 130 132 128 129 130 132 80 80 55 58 58 81 84 89 89 91 91 90 89 84 87 81 85 84 86 84 86 86 88 87 85 84 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 98% 98% 99% 99% 99% 99% 98% 98% 99% 150 4 7 4 4 4 3 3 3 2 2 3 3 2 3 2 2 2 2 2 3 2 1 1 1 1 1 2 0
SRILEKHA 34 F 52 145 B I PARAUMBILICALHERNIA REPAIR 72/100% 78/100% 74/100% 75/100% 76/100% 74/100% 77/100% 80/100% 78 81 84 87 88 74 75 76 76 74 76 71 72 76 71 61 62 64 64 66 66 65 66 68 63 114 110 120 122 129 131 134 131 128 126 127 125 121 122 119 117 118 119 118 114 121 122 126 119 111 112 74 72 78 78 79 81 84 84 79 79 79 76 74 74 73 73 71 71 70 71 72 77 77 75 74 74 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 99% 99% 99% 100% 99% 99% 99% 100% 90 3 5 3 6 6 3 3 3 3 3 2 1 1 3 1 1 1 1 2 2 2 2 2 2 2 1 2 0
TINKU DOSS 46 F 51 150 A II  INCISIONAL HERNIA 74/100% 76/100% 74/100% 76/100% 74/100% 77/100% 73/100% 72/100% 78 90 96 90 84 85 86 86 84 82 81 84 83 86 85 84 83 81 79 77 74 79 77 74 74 130 140 130 141 142 130 126 128 129 126 126 126 124 140 140 139 136 139 136 134 130 129 121 129 121 124 80 90 89 101 102 101 100 89 86 89 89 89 85 90 91 90 92 90 96 90 96 84 85 86 84 85 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 98% 98% 99% 99% 99% 99% 99% 99% 150 6 4 4 4 5 6 4 3 3 3 3 2 2 1 1 1 1 1 2 2 2 2 2 2 2 2 1 0
ROSHMA 19 F 51 149 B I APPENDICECTOMY 96/100% 98/100% 99/100% 96/100% 95/100% 94/100% 93/100% 92/100% 104 97 102 87 84 80 84 86 85 84 85 81 79 79 77 81 80 83 84 85 86 87 88 85 84 124 122 110 120 116 116 116 121 126 129 130 126 121 122 123 126 121 128 121 117 116 117 116 117 116 116 76 76 68 76 76 72 72 74 78 79 89 76 74 74 74 74 75 76 77 72 71 73 74 71 69 68 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 99% 99% 99% 98% 98% 98% 98% 99% 100% 75 2 2 2 3 6 4 4 3 5 6 4 3 2 3 3 2 1 2 2 2 2 2 2 2 2 2 5 0
DHANA SINGH 48 M 70 145 A I  INCISIONAL HERNIA 72/100% 74/100% 76/100% 72/100% 74/100% 75/100% 74/100% 73/100% 96 74 77 76 78 84 85 84 86 91 92 94 90 91 90 94 90 89 85 80 85 84 80 84 80 116 90 120 124 126 118 119 126 128 140 141 143 140 160 140 141 142 140 139 130 127 126 126 126 128 126 70 50 66 78 84 78 85 86 84 98 99 98 96 99 89 86 86 86 85 84 83 82 82 82 84 84 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 99% 100% 99% 99% 99% 99% 98% 99% 99% 99% 105 3 6 4 4 6 3 4 3 4 3 3 2 2 1 1 1 1 1 1 1 2 2 2 2 2 2 2 0
VIGNESH 18 M 66 149 A I APPENDICECTOMY 80/100% 81/100% 84/100% 84/100% 80/100% 83/100% 82/100% 81/100% 78 96 85 67 63 66 68 96 98 84 85 84 83 84 75 73 72 71 71 70 69 72 74 76 78 120 112 114 120 118 119 101 108 127 130 132 130 128 129 132 129 125 124 120 118 119 118 119 119 119 121 76 72 75 76 75 79 61 63 85 86 88 85 84 83 84 80 80 81 82 79 79 77 75 76 73 79 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 99% 99% 100% 100% 99% 98% 98% 98% 98% 99% 90 1 3 6 5 4 4 3 2 2 2 3 3 2 3 2 1 1 1 1 1 1 1 1 2 1 1 3 0
AMBIKA 36 F 51 155 A I OPENCHOLECYSTECTOMY 76/100% 75/100% 76/100% 75/100% 75/100% 74/100% 73/100% 72/100% 77 76 80 85 84 85 88 80 89 80 84 86 85 83 84 86 85 86 90 89 89 89 80 85 83 120 98 121 116 117 118 119 130 132 132 134 131 136 132 136 140 133 129 126 123 124 126 125 126 125 120 76 65 71 70 73 78 79 84 85 81 86 84 85 82 80 89 83 84 82 81 81 86 85 83 86 80 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 99% 100% 99% 98% 98% 99% 99% 99% 98% 98% 99% 75 4 4 3 5 5 4 3 3 2 2 3 2 2 1 1 1 1 1 2 2 2 2 2 2 2 2 1 0
MATHIYALAGAN 46 M 78 148 A I PARAUMBILICALHERNIA REPAIR 67/100% 69/100% 63/100% 65/100% 67/100% 66/100% 66/100% 65/100% 67 78 62 65 78 77 77 78 81 83 84 88 89 90 84 85 88 89 84 85 84 86 87 80 88 89 100 94 99 113 122 124 126 127 120 123 130 114 114 116 121 126 127 128 129 130 130 130 126 116 118 119 60 61 72 86 96 96 92 90 86 81 77 77 77 81 84 85 86 86 90 89 89 85 74 76 75 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 98% 99% 100% 100% 99% 99% 99% 98% 99% 100% 120 5 4 5 5 4 5 5 6 3 2 2 2 2 1 1 1 2 2 1 1 1 1 2 1 1 2 1 0
JAYALAKSHMI 41 F 63 160 A I PARAUMBILICALHERNIA REPAIR 78/100% 79/100% 74/100% 79/100% 72/100% 74/100% 74/100% 75/100% 84 86 92 90 91 88 84 81 92 96 88 84 83 84 85 87 88 84 82 84 88 89 81 84 85 120 119 120 131 132 131 140 141 135 136 131 129 128 127 126 119 116 119 122 131 122 126 124 120 121 119 80 85 88 91 96 94 98 98 85 87 81 81 86 85 85 84 84 83 82 82 82 77 79 79 77 72 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 97% 97% 98% 99% 99% 98% 100% 98% 98% 99% 99% 105 6 5 5 4 4 3 4 4 2 2 3 2 2 1 1 1 2 2 2 2 1 2 1 2 2 2 1 0
BABY 46 F 49 143 A II  INCISIONAL HERNIA 90/100% 84/100% 85/100% 84/100% 83/100% 82/100% 81/100% 80/1005 101 94 93 86 91 88 87 84 84 86 87 84 86 89 91 92 84 88 86 85 86 87 88 91 80 82 96 99 117 118 140 140 138 134 128 136 140 132 128 126 128 131 132 134 136 128 129 116 112 114 116 122 61 65 89 86 102 96 94 95 96 99 94 92 90 85 89 89 89 89 84 84 83 74 77 78 79 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 99% 99% 100% 100% 99% 98% 98% 98% 98% 150MINS 6 5 5 5 4 6 5 3 2 2 3 2 1 1 1 1 2 2 1 1 2 2 2 2 2 2 1 0
ALKATHA BEGUM 48 F 67 148 B II INCISIONAL HERNIA 72/100% 66/100% 60/100% 59/100% 62/100% 61/100% 60/100% 62/100% 62 58 56 57 55 54 58 55 56 57 58 54 52 53 58 60 63 64 64 62 60 64 62 63 64 137 119 130 128 127 128 131 132 129 1229 130 126 124 128 131 131 136 140 128 126 119 118 119 120 122 124 85 72 94 91 90 88 86 86 87 89 87 88 84 81 79 88 85 86 84 88 84 84 84 83 81 82 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 99% 99% 99% 100% 99% 99% 99% 100% 150 3 3 5 5 7 6 6 4 4 4 3 2 1 3 3 2 2 2 1 1 2 2 2 1 1 1 3 0
SRINIVASAN 53 M 68 166 B I  INCISIONAL HERNIA 66/100% 65/100% 67/100% 68/100% 66/100% 65/100% 63/100% 66/100% 71 66 65 63 60 62 61 65 67 71 72 73 74 71 66 68 69 71 73 74 76 77 78 71 74 122 106 128 121 127 131 140 142 143 160 150 140 128 121 106 112 113 114 118 121 122 123 124 128 130 131 80 60 74 80 90 94 94 99 99 102 104 96 81 84 84 82 84 76 78 72 74 73 74 78 74 74 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 98% 98% 99% 99% 99% 99% 99% 99% 150 2 2 2 5 4 4 5 3 2 1 1 1 1 3 3 1 1 1 2 2 2 1 1 2 1 1 4 0
MURUGAN 36 M 65 158 B II PARAUMBILICALHERNIA REPAIR 92/100% 96/100% 90/100% 87/100% 86/100% 84/100% 88/100% 80/100% 111 106 99 92 112 106 99 102 98 94 90 81 88 72 76 86 88 89 79 87 92 82 83 84 92 124 140 122 106 120 140 130 142 146 132 128 117 112 140 106 102 112 122 131 129 131 140 132 126 121 119 72 92 84 71 76 96 84 91 96 81 79 70 66 92 78 71 74 85 80 78 80 91 72 76 77 75 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 99% 99% 99% 98% 98% 98% 98% 99% 100% 150 3 5 5 5 4 6 5 4 4 4 4 4 4 5 4 2 2 1 2 1 1 1 1 1 1 1 1 0
JAYANTHI 49 F 53 153 B I  INCISIONAL HERNIA 80/100% 79/100% 74/100% 75/100% 75/100% 69/100% 71/100% 72/100% 81 92 89 91 96 87 83 80 76 72 70 69 58 76 77 81 88 85 86 80 78 79 79 76 81 122 116 150 131 126 121 119 112 131 118 106 101 106 112 118 131 112 114 112 114 120 126 128 118 116 118 78 80 100 84 82 79 84 78 81 69 66 64 66 71 78 78 71 76 72 72 82 84 81 78 78 78 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 99% 100% 99% 99% 99% 99% 98% 99% 99% 99% 135 0 2 2 5 5 7 7 6 5 5 4 3 2 5 4 4 4 4 3 2 2 2 1 1 1 1 4 0
SUGUNA 30 F 61 159 B I  INCISIONAL HERNIA 76/100% 78/100% 77/100% 78/100% 77/100% 77/100% 71/100% 72/100% 71 72 74 71 74 71 69 65 78 77 71 74 72 76 71 76 78 81 84 81 86 88 76 74 76 108 100 101 106 108 131 111 111 112 130 111 114 118 117 119 121 126 128 121 134 121 118 116 119 122 124 66 56 53 56 55 75 67 66 66 81 65 65 65 66 66 74 78 72 71 75 74 74 71 68 68 72 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 99% 99% 100% 100% 99% 98% 98% 98% 98% 99% 105 0 1 3 3 6 4 5 5 6 5 4 4 3 5 4 4 4 3 3 2 2 2 1 1 1 1 5 0
NASIMA BEGUM 34 F 58 155 B I PARAUMBILICALHERNIA REPAIR 72/100% 70/100% 74/100% 75/100% 74/100% 76/100% 74/100% 74/100% 65 66 69 71 74 69 65 66 68 71 74 76 75 76 78 79 74 74 76 81 74 74 76 78 79 112 100 101 101 101 122 106 100 105 106 108 109 112 114 128 116 116 117 118 116 128 115 116 116 116 116 68 58 60 61 62 68 60 60 61 61 60 61 65 66 78 66 65 63 62 70 78 66 69 58 69 66 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 99% 100% 99% 98% 98% 99% 99% 99% 98% 98% 99% 90 0 0 3 4 5 4 4 4 6 3 3 2 3 5 4 4 4 4 3 3 2 2 1 1 1 1 5 0
SHAKILA 41 F 72 165 B I  INCISIONAL HERNIA 74/100% 72/100% 73/100% 74/100% 75/100% 76/100% 76/100% 72/100% 78 79 87 81 86 82 84 90 91 94 81 81 82 83 87 88 89 90 82 84 84 83 78 78 78 130 106 105 111 121 130 136 136 128 129 110 121 121 130 140 137 139 129 121 121 119 119 118 120 120 129 80 65 66 68 84 86 88 88 78 78 72 80 79 83 90 85 90 85 83 83 79 78 78 76 76 77 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 98% 98% 99% 99% 99% 99% 98% 98% 99% 115 2 4 5 5 5 7 4 4 3 2 2 1 1 2 3 2 2 3 2 2 2 2 2 2 2 2 3 0
ROJAMMAL 21 F 53 150 B I APPENDICECTOMY 96/100% 94/100% 93/100% 92/100% 91/100% 90/100% 93/100% 95/100% 91 87 85 85 86 84 88 84 81 78 79 76 77 81 84 91 90 84 88 81 84 82 80 78 75 110 92 102 111 112 114 120 121 121 121 126 121 130 128 140 121 123 125 118 119 114 116 122 123 125 126 70 54 58 60 61 62 63 66 68 71 74 69 81 78 86 78 77 71 66 69 66 65 69 71 74 75 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 99% 99% 99% 100% 99% 99% 99% 100% 90 1 2 2 2 5 4 4 7 5 4 4 2 2 5 3 3 3 3 2 2 2 2 2 2 2 1 5 RSD
JENIFER HANCY 25 F 60 160 B I APPENDICECTOMY 77/100% 78/100% 79/100% 79/100% 78/100% 75/100% 76/100% 77/100% 84 71 74 71 69 68 64 63 65 81 83 84 80 88 96 91 90 88 85 84 84 81 78 79 83 121 102 106 112 114 116 114 115 121 126 121 126 128 121 124 126 124 125 130 129 114 116 111 117 118 126 69 60 60 59 69 66 68 67 76 74 75 76 78 75 74 74 73 77 81 80 72 72 73 74 74 78 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 98% 98% 99% 99% 99% 99% 99% 99% 60 2 2 5 4 4 6 7 6 5 4 3 2 2 4 3 3 3 2 2 2 1 1 1 3 1 1 3 0
BHARATH KUMAR 28 M 71 144 B I  INCISIONAL HERNIA 96/100% 94/100% 102/100% 101/100% 99/100% 96/100% 97/100% 98/100% 88 86 85 84 85 84 87 88 91 92 91 81 81 82 84 84 84 83 78 77 76 77 79 71 74 110 121 126 121 131 132 121 121 126 127 126 121 128 129 120 131 134 121 121 121 121 120 121 120 124 126 70 84 91 92 96 98 88 84 84 84 84 84 85 86 85 85 84 85 84 83 82 82 81 80 84 85 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 99% 99% 99% 98% 98% 98% 98% 99% 100% 105 3 4 4 5 7 6 5 4 4 3 2 2 1 4 3 2 2 2 2 2 2 1 1 1 1 1 4 NA
GAYATHRI 39 F 65 144 A I  INCISIONAL HERNIA 74/100% 74/100% 75/100% 76/100% 76/100% 75/100% 74/100% 76/100% 70 69 73 74 76 77 78 81 83 84 88 89 90 84 85 88 89 84 85 84 86 87 80 88 89 130 120 130 130 124 125 126 127 120 123 130 114 114 116 121 126 127 128 129 130 130 130 126 116 118 119 80 84 86 92 84 89 91 92 90 86 81 77 77 77 81 84 85 86 86 90 89 89 85 74 76 75 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 99% 100% 99% 99% 99% 99% 98% 99% 99% 99% 90 4 5 5 5 4 4 5 5 4 4 3 2 1 2 2 2 2 2 1 2 1 1 2 1 1 1 2 0
MOHINI 36 F 60 157 B I PARAUMBILICALHERNIA REPAIR 81/100% 80/100% 79/100% 81/100% 80/100% 84/100% 79/100% 77/100% 82 77 82 84 73 69 66 68 72 81 80 78 78 80 84 81 82 84 80 79 83 84 81 82 84 126 106 97 122 117 123 118 125 134 117 131 114 110 110 111 114 116 110 110 111 112 114 112 118 119 119 84 63 64 78 85 74 76 79 84 66 82 73 71 72 72 76 78 72 70 69 67 69 66 66 72 72 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 99% 99% 100% 100% 99% 98% 98% 98% 98% 99% 120 0 2 5 4 4 4 4 5 4 5 3 2 2 5 4 2 2 2 2 1 1 1 1 1 1 1 3 0
LAKSHMI 37 F 64 159 A I  INCISIONAL HERNIA 76/100% 74/100% 76/100% 76/100% 76/100% 76/100% 74/100% 77/100% 76 88 84 81 84 86 88 89 91 90 88 84 84 84 88 81 78 79 84 88 84 84 82 84 88 121 130 118 130 132 131 140 141 130 130 140 132 136 138 132 136 138 126 122 121 128 121 122 120 121 120 76 80 82 91 96 90 96 100 96 92 91 96 98 98 92 90 98 90 88 84 84 86 82 81 81 80 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 98% 98% 99% 99% 99% 99% 98% 98% 99% 150 5 4 4 5 6 5 5 4 4 4 3 2 1 1 1 1 2 2 2 1 1 2 2 2 2 2 1 0
GANGA 19 F 52 148 B I APPENDICECTOMY 102/100% 106/100% 108/100% 106/100% 99/100% 94/100% 92/100% 94/100% 96 105 102 101 106 104 99 95 96 91 90 90 88 85 84 81 85 84 86 88 86 85 84 84 80 121 121 106 116 114 116 117 121 121 126 126 126 126 125 123 124 126 126 121 118 118 118 116 119 118 114 69 84 88 82 81 80 81 87 81 84 85 85 85 79 76 76 76 78 78 79 70 72 72 70 68 72 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 99% 99% 99% 100% 99% 99% 99% 100% 105 2 3 5 4 4 6 5 5 4 3 2 1 1 3 3 2 1 1 1 1 1 1 1 1 1 1 3 0
MARI 47 M 68 147 B I  INCISIONAL HERNIA 72/100% 69/100% 68/100% 67/100% 65/100% 66/100% 67/100% 63/100% 68 61 74 78 81 94 80 81 78 75 76 81 84 85 78 71 75 76 75 76 77 76 76 77 78 128 101 122 128 131 132 133 132 140 121 117 118 121 122 122 124 121 120 126 127 128 121 129 122 124 129 79 64 65 74 91 90 91 86 89 78 79 71 71 74 72 74 74 76 74 77 78 74 78 74 76 75 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 98% 98% 99% 99% 99% 99% 99% 99% 90 2 2 2 5 5 4 2 1 1 1 1 1 1 3 3 3 2 1 1 1 1 2 1 2 1 1 4 0
NAGESHWARI 45 F 77 158 B I PARAUMBILICALHERNIA REPAIR 80/100% 79/100% 74/100% 75/100% 75/100% 69/100% 71/100% 72/100% 70 71 76 78 81 84 85 78 79 81 84 86 88 84 85 88 89 92 90 84 80 79 72 74 73 120 100 128 131 134 132 128 121 116 128 129 131 132 130 121 129 129 130 130 128 129 122 122 121 124 126 80 60 88 84 88 91 92 94 81 84 85 86 81 85 84 85 86 85 83 84 84 80 84 82 82 80 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 99% 99% 99% 98% 98% 98% 98% 99% 100% 145 1 3 5 3 2 2 2 3 2 2 1 1 1 3 3 1 1 2 2 2 2 1 1 1 1 1 3 NA
VASANTHA 26 F 59 162 B I  INCISIONAL HERNIA 72/100% 76/100% 77/100% 71/100% 69/100% 71/100% 72/100% 70/100% 81 81 91 102 94 91 98 103 90 88 80 84 88 90 84 80 78 71 74 70 84 82 81 82 84 116 101 116 121 140 130 132 136 142 128 121 119 126 131 132 126 131 125 121 121 119 121 126 131 128 129 72 65 69 74 90 86 85 84 92 87 83 76 84 85 88 81 86 80 77 77 75 74 76 79 74 76 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 99% 100% 99% 99% 99% 99% 98% 99% 99% 99% 150 2 5 4 5 5 4 4 4 6 4 2 2 1 3 3 3 3 2 2 2 2 2 3 2 2 1 2 V
LAKSHMI 35 F 66 161 A I APPENDICECTOMY 76/100% 72/100% 70/100% 69/100% 72/100% 74/100% 72/100% 74/100% 101 96 98 91 88 87 84 84 86 87 84 86 89 91 92 84 88 86 85 86 87 88 91 80 82 120 100 129 130 140 140 138 134 128 136 140 132 128 126 128 131 132 134 136 128 129 116 112 114 116 122 80 64 86 82 100 102 96 94 95 96 99 94 92 90 85 89 89 89 89 84 84 83 74 77 78 79 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 99% 99% 100% 100% 99% 98% 98% 98% 98% 99% 120 6 5 5 5 4 6 5 3 2 2 3 2 1 1 1 1 2 2 1 1 2 2 2 2 2 2 1 0
SEETHARAMAN 59 M 74 157 B II  INCISIONAL HERNIA 72/100% 69/100% 63/100% 65/100% 66/100% 67/100% 66/100% 65/100% 69 65 61 62 63 61 60 59 62 61 65 67 69 72 73 74 75 76 70 66 65 66 65 68 71 139 130 128 131 140 155 156 161 120 121 140 131 126 128 121 122 128 126 127 127 128 127 128 131 131 134 84 80 86 94 99 99 98 96 97 91 90 88 86 84 85 86 84 81 82 84 84 82 84 88 81 82 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 98% 99% 100% 100% 99% 99% 99% 98% 99% 100% 150 3 3 5 6 5 6 5 4 3 3 3 2 1 3 2 2 2 2 2 2 2 2 2 1 1 1 3 G
SIVA KUMAR 46 M 71 165 A I  INCISIONAL HERNIA 74/100% 76/100% 71/100% 70/100% 67/100% 69/100% 69/100% 72/100% 71 76 78 81 77 69 64 63 64 72 76 77 81 84 88 91 92 90 91 96 90 88 80 78 76 136 112 138 140 142 146 142 146 142 141 138 139 136 138 131 128 129 121 131 138 136 136 134 130 128 124 82 66 86 85 83 88 89 89 91 91 90 87 85 86 84 86 85 84 88 81 89 88 84 83 78 79 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 98% 98% 99% 99% 99% 99% 99% 99% 120 6 5 5 4 4 3 4 4 2 2 3 2 2 1 1 1 2 2 2 2 1 2 1 2 2 2 1 0
SHYAMALA 58 F 68 141 B I  INCISIONAL HERNIA 74/100% 68/100% 69/100% 68/100% 65/100% 66/100% 63/100% 62/100% 69 65 59 57 58 59 56 58 59 55 61 65 66 72 71 72 69 65 64 66 61 64 63 62 60 140 140 140 136 128 126 126 128 126 127 128 126 128 129 124 130 131 136 132 134 132 136 132 136 136 138 90 62 90 91 98 87 81 84 85 86 88 88 89 84 83 86 87 86 81 82 83 84 88 88 84 83 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 99% 99% 99% 98% 98% 98% 98% 99% 100% 135 3 3 3 6 4 5 4 3 3 2 2 2 2 3 2 2 2 2 2 1 1 1 1 1 1 1 3 G
VASANTHA 60 F 59 166 B II  INCISIONAL HERNIA 66/100% 65/100% 64/100% 64/100% 65/100% 66/100% 66/100% 67/100% 69 65 66 69 68 71 76 78 73 75 71 69 66 65 60 58 61 65 63 65 66 61 64 66 68 140 130 128 140 150 128 128 126 128 128 128 124 122 122 128 130 140 141 126 128 128 128 128 128 121 130 90 90 88 94 96 88 88 84 85 87 84 85 86 87 88 89 88 89 84 85 85 85 84 85 81 82 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 99% 100% 99% 99% 99% 99% 98% 99% 99% 99% 135 3 3 6 4 5 5 4 3 2 2 2 2 2 3 2 1 2 1 1 2 1 1 1 1 1 1 3 0
ARUN KUMAR 23 M 69 148 A I PARAUMBILICALHERNIA REPAIR 69/100% 66/100% 69/100% 65/100% 64/100% 69/100% 69/100% 69/100% 66 72 79 77 74 81 82 79 75 70 76 74 77 78 71 76 76 75 71 70 69 66 69 76 72 110 99 130 131 132 134 130 128 119 112 116 118 128 121 132 131 129 122 124 129 126 121 119 121 130 122 70 58 88 89 84 86 82 80 78 79 79 82 81 83 80 84 82 82 78 79 81 82 81 72 73 74 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 99% 99% 100% 100% 99% 98% 98% 98% 98% 99% 75 5 4 4 4 6 6 4 3 3 3 2 2 3 1 1 2 1 2 2 2 1 2 1 1 1 1 1 0
VENKADESAN 47 M 72 158 A I  INCISIONAL HERNIA 66/100% 68/100% 66/100% 69/100% 68/100% 64/100% 69/100% 65/100% 77 81 90 94 81 66 65 64 65 78 84 88 84 81 82 86 88 90 91 90 82 87 84 84 84 120 102 112 128 131 134 136 138 128 121 126 127 128 129 121 129 129 129 127 125 122 119 112 116 118 119 75 66 68 69 72 74 74 84 81 81 81 84 84 84 81 82 85 84 84 81 88 78 77 75 73 72 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 99% 100% 99% 98% 98% 99% 99% 99% 98% 98% 99% 90 7 5 5 5 4 4 4 3 5 3 2 2 2 1 1 1 1 2 2 1 2 2 1 1 1 1 1 0
PUGAZHINMI 45 M 66 160 A I PARAUMBILICALHERNIA REPAIR 76/100% 70/100% 66/100% 60/100% 56/100% 58/100% 59/100% 63/100% 80 76 70 66 68 70 66 72 70 74 73 76 72 76 81 86 84 85 84 86 78 79 77 76 76 110 120 130 140 120 140 106 110 108 100 112 144 130 132 136 131 131 128 126 127 126 126 122 118 118 118 70 76 80 82 80 70 74 80 74 70 70 82 86 76 76 76 79 74 71 76 76 77 78 77 71 70 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 98% 98% 99% 99% 99% 99% 98% 98% 99% 120 3 5 3 4 3 4 4 4 3 3 2 3 3 1 1 1 2 2 2 2 2 2 2 2 2 2 2 0
SENBAGAM 40 F 65 160 B I PARAUMBILICALHERNIA REPAIR 84/100% 82/100% 80/100% 78/100% 77/100% 75/100% 76/100% 71/100% 78 79 79 84 89 84 84 84 86 87 84 85 86 89 84 83 81 79 78 79 79 77 74 72 74 119 114 121 122 126 124 123 121 126 128 130 132 131 132 130 121 126 121 128 118 119 119 121 120 122 120 69 66 81 84 89 84 84 89 80 88 88 84 88 84 84 84 83 82 89 80 79 79 79 81 82 84 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 99% 99% 99% 100% 99% 99% 99% 100% 135 1 3 4 3 3 2 2 2 3 2 2 2 1 3 3 3 2 2 2 2 2 2 2 2 2 2 3 0
SENTHILKUMAR 39 M 59 161 B I  INCISIONAL HERNIA 74/100% 76/100% 72/100% 78/100% 70/100% 71/100% 69/100% 72/100% 76 76 78 79 84 81 82 79 76 74 76 79 84 82 84 81 78 79 77 74 73 72 74 74 77 136 84 101 119 118 126 118 119 130 126 128 118 129 122 126 126 124 120 118 126 122 126 131 134 138 146 82 62 66 74 72 81 80 81 86 88 88 80 89 86 86 86 80 84 82 84 85 85 89 89 89 89 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 98% 98% 99% 99% 99% 99% 99% 99% 150 3 3 6 2 3 3 2 2 2 2 1 1 1 3 3 2 2 2 1 1 2 2 3 2 2 2 3 0
LAKSHMI 33 F 69 158 B II  INCISIONAL HERNIA 76/100% 77/100% 79/100% 76/100% 74/100% 72/100% 71/100% 70/100% 89 84 84 83 82 80 79 81 80 84 82 84 89 89 84 79 79 77 76 74 76 77 76 79 78 119 140 140 139 138 136 128 126 121 126 126 128 129 121 118 118 109 116 116 118 124 126 128 130 126 128 61 91 90 90 91 92 90 89 89 84 84 86 84 86 80 79 79 72 74 76 78 82 84 84 84 84 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 99% 99% 99% 98% 98% 98% 98% 99% 100% 105 3 3 5 3 2 2 3 2 2 2 2 1 1 3 2 2 3 2 2 2 2 2 2 2 2 2 3 0
MANIMARAN 42 M 70 166 A I  INCISIONAL HERNIA 92/100% 90/100% 88/100% 85/100% 84/100% 85/100% 84/100% 80/100% 78 79 81 84 86 88 89 85 84 85 81 80 79 78 79 76 78 79 77 74 76 77 77 74 74 130 140 128 129 131 129 128 126 127 125 118 126 118 119 118 121 120 122 120 123 124 126 128 128 129 118 80 97 89 84 85 86 86 87 84 83 82 84 82 83 84 85 84 80 78 79 80 81 84 85 85 80 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 99% 100% 99% 99% 99% 99% 98% 99% 99% 99% 150 5 4 3 3 3 4 3 3 4 3 2 2 1 1 1 1 2 2 2 2 2 1 2 2 2 2 1 0
RAFEEQ AHAMED 45 M 73 167 A I  INCISIONAL HERNIA 60/100% 66/100% 63/100% 62/100% 69/100% 69/100% 68/100% 65/100% 78 66 65 63 66 69 81 84 85 84 89 85 84 80 84 84 83 84 83 85 84 89 80 80 84 126 140 136 132 128 129 129 128 127 130 132 131 130 134 138 134 139 130 136 130 132 128 126 128 126 127 78 92 90 91 90 89 89 86 87 89 85 80 82 83 85 89 89 80 86 84 82 84 80 82 80 80 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 99% 99% 100% 100% 99% 98% 98% 98% 98% 99% 120 4 6 5 5 5 4 3 4 3 3 2 2 1 1 1 1 1 2 1 1 2 2 2 2 1 1 1 0
PRABAKAR RAO 48 M 77 165 A I PARAUMBILICALHERNIA REPAIR 69/100% 68/100% 71/100% 76/100% 74/100% 77/100% 70/100% 74/100% 77 78 79 80 81 84 85 85 86 89 85 84 82 78 79 75 77 76 77 76 74 74 76 77 78 122 120 121 130 132 128 126 120 124 124 118 119 126 128 129 130 131 130 129 128 129 126 125 124 121 124 79 80 79 80 86 84 84 80 82 80 76 79 75 79 84 86 88 80 82 80 84 82 80 84 83 84 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 98% 98% 99% 99% 99% 99% 98% 98% 99% 150 3 6 4 3 4 4 4 3 2 3 3 3 2 1 1 1 1 2 2 2 2 2 2 2 2 2 2 0
VIJAYA 26 F 64 168 A I  INCISIONAL HERNIA 64/100% 68/100% 74/100% 72/100% 74/100% 76/100% 77/100% 79/100% 86 88 84 89 84 85 88 79 86 86 85 89 90 91 92 91 89 86 84 85 84 83 82 80 80 130 130 126 128 136 138 129 129 126 120 122 124 126 120 155 156 140 140 140 130 136 130 132 130 130 126 80 90 88 90 96 94 90 94 90 84 84 85 87 96 91 98 94 90 90 87 89 80 86 80 84 82 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 99% 99% 99% 100% 99% 99% 99% 100% 135 5 3 4 4 3 4 3 3 3 3 2 2 2 1 1 1 1 2 2 2 1 1 1 1 2 2 1 0
UMA
MAHESWARI 26 F 55 160 B I  INCISIONAL HERNIA 80/100% 71/100% 74/100% 73/100% 74/100% 74/100% 76/100% 70/100% 80 77 76 71 76 70 71 74 77 76 74 76 77 78 84 84 82 81 84 82 84 83 80 84 82 112 116 130 131 136 132 134 102 128 121 118 116 117 118 116 121 124 124 126 126 126 124 126 130 132 133 76 66 86 89 89 91 94 60 66 72 71 66 66 64 65 81 82 81 81 80 86 80 80 88 87 85 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 98% 98% 99% 99% 99% 99% 99% 99% 120 2 3 6 3 2 2 2 3 3 1 1 1 1 3 3 3 2 2 1 2 2 2 2 2 2 2 3 0
GOPAL MOORTHY 52 M 67 166 B I  INCISIONAL HERNIA 66/100% 65/100% 63/100% 65/100% 63/100% 63/100% 64/100% 65/100% 68 67 68 69 71 74 76 74 75 77 78 79 80 76 71 66 65 66 64 63 64 66 65 63 61 130 130 128 121 126 124 123 121 118 119 121 130 126 126 129 128 120 119 106 108 106 106 102 106 118 111 80 90 89 86 88 80 84 85 84 75 76 87 85 85 84 85 80 75 76 66 65 60 60 60 65 66 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 99% 99% 99% 98% 98% 98% 98% 99% 100% 135 1 2 2 5 3 2 2 2 2 2 2 2 2 3 3 3 3 2 2 2 2 2 2 1 1 1 4 0
THANGAVELU 41 M 69 170 A I  INCISIONAL HERNIA 78/100% 79/100% 84/100% 85/100% 89/100% 85/100% 79/100% 77/100% 74 78 84 85 86 84 82 84 86 90 86 89 88 84 85 84 85 86 86 84 83 82 81 81 80 118 112 114 126 126 118 118 126 122 124 130 124 126 121 121 122 124 126 126 121 126 121 120 118 118 124 70 61 62 66 81 84 84 88 89 89 89 89 78 81 82 89 84 86 86 81 88 84 80 82 82 84 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 99% 100% 99% 99% 99% 99% 98% 99% 99% 99% 120 3 6 3 3 4 3 4 3 2 1 1 1 1 2 2 2 3 2 2 2 2 2 2 2 2 2 2 0
ELUMALAI 45 M 80 167 A II  INCISIONAL HERNIA 74/100% 77/100% 72/100% 74/100% 70/100% 69/100% 65/100% 64/100% 80 67 68 67 60 58 59 61 64 66 61 63 62 66 65 66 67 68 69 60 72 73 74 72 72 140 118 130 142 138 130 128 121 126 123 124 126 130 134 139 142 132 130 131 130 130 129 121 124 126 128 90 69 84 96 90 92 90 88 84 84 84 84 83 89 89 91 90 84 85 80 85 79 76 74 73 74 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 99% 99% 100% 100% 99% 98% 98% 98% 98% 99% 150 6 5 4 4 4 5 4 4 5 4 4 4 3 1 1 1 2 3 2 2 2 2 2 1 2 2 1 0
RAJESH KUMAR 28 M 74 169 A I  INCISIONAL HERNIA 66/100% 65/100% 64/100% 63/100% 62/100% 61/100% 60/100% 63/100% 90 66 65 66 64 63 64 60 59 67 63 64 63 64 63 66 66 63 66 65 66 63 66 63 66 120 121 118 116 118 106 106 104 106 96 128 121 118 119 117 119 118 121 124 126 121 121 119 116 116 118 75 79 78 77 77 70 66 62 60 58 78 71 73 74 73 74 72 73 76 72 70 72 70 68 69 69 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 99% 100% 99% 98% 98% 99% 99% 99% 98% 98% 99% 120 0 2 5 3 2 2 2 2 2 2 2 2 2 4 3 2 2 2 2 2 2 2 2 2 2 2 3 V
AMUTHA 38 F 63 155 A I APPENDICECTOMY 79/100% 79/100% 84/100% 81/100% 82/100% 83/100% 80/100% 84/100% 77 66 61 61 62 66 63 64 66 65 66 66 72 77 72 73 74 75 71 72 78 71 78 77 72 118 90 111 112 114 116 118 121 118 119 121 122 123 130 128 129 129 121 130 118 119 122 123 121 124 125 66 65 66 66 68 68 69 72 73 74 74 76 78 90 91 90 91 81 84 81 84 82 82 80 82 80 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 98% 98% 99% 99% 99% 99% 98% 98% 99% 140 4 5 3 3 3 2 2 2 2 2 2 2 2 3 3 2 2 2 2 2 2 2 2 2 2 2 2 0
KANNAIYAN 49 M 68 167 A I  INCISIONAL HERNIA 64/100% 60/100% 65/100% 64/100% 66/100% 60/100% 63/100% 64/100% 64 78 77 71 66 65 63 60 58 56 57 59 59 53 54 59 58 59 58 59 55 60 63 64 62 128 132 130 121 124 11`8 118 116 112 116 111 114 113 112 106 130 130 130 130 132 130 130 130 128 121 121 84 80 84 80 78 79 77 76 75 74 70 72 74 72 66 90 91 90 86 85 85 85 85 84 80 82 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 99% 99% 99% 100% 99% 99% 99% 100% 150 2 5 3 3 3 4 5 5 4 4 3 3 3 3 1 2 2 2 2 2 1 2 2 2 2 2 2 0
DILLI BABU 41 M 78 170 A II  INCISIONAL HERNIA 80/100% 82/100% 80/100% 79/100% 77/100% 76/100% 77/100% 70/100% 81 80 78 77 81 84 83 84 80 81 84 85 89 90 91 92 90 88 84 84 85 80 80 80 82 130 140 141 139 133 128 121 118 118 111 121 130 133 140 141 142 141 130 136 130 138 131 136 130 132 130 80 96 96 95 90 90 88 80 83 80 86 89 89 94 91 96 91 86 84 83 83 80 86 80 80 80 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 98% 98% 99% 99% 99% 99% 99% 99% 150 7 5 5 4 4 4 3 3 3 4 3 4 3 1 1 1 2 2 2 2 2 2 2 2 2 2 1 0
VIJAYAKUMARI 34 F 65 158 A II  INCISIONAL HERNIA 86/100% 85/100% 84/100% 86/100% 84/100% 85/100% 86/100% 81/100% 86 84 84 83 80 78 76 77 74 75 76 90 94 90 94 90 88 84 88 84 83 80 84 85 80 122 120 128 130 121 126 121 121 123 124 126 129 130 131 130 131 136 130 129 120 120 121 122 124 123 126 76 72 77 77 81 84 80 80 84 82 84 89 89 84 90 90 94 90 84 80 80 82 80 82 84 80 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 99% 99% 99% 98% 98% 98% 98% 99% 100% 90 5 3 4 3 4 3 3 4 3 3 3 3 3 1 2 1 2 1 2 1 2 2 1 2 2 2 1 0
RASATHIYAMMAL 45 F 75 160 A II  INCISIONAL HERNIA 74/100% 75/100% 79/100% 84/100% 80/100% 80/100% 85/100% 82/100% 86 87 89 81 80 78 79 77 79 74 71 74 80 85 86 86 85 86 80 85 981 81 80 88 90 140 130 132 128 121 121 120 121 122 124 121 129 131 132 134 130 130 138 130 131 132 130 133 136 130 130 90 80 82 80 81 89 84 80 81 80 81 83 86 89 89 80 79 89 84 82 80 81 80 84 83 80 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 98% 99% 100% 99% 99% 99% 99% 98% 99% 99% 99% 150 3 3 4 3 3 3 3 3 2 2 2 3 3 3 2 1 1 2 2 2 3 2 2 2 2 2 3 0
CHINRASU 38 M 73 159 A I  INCISIONAL HERNIA 74/100% 77/100% 81/100% 84/100% 83/100% 84/100% 83/100% 84/100% 90 92 94 93 76 77 76 78 79 79 84 83 85 86 87 80 85 84 85 83 84 80 80 82 84 130 140 140 138 136 130 128 126 130 121 121 140 136 138 130 140 141 130 130 132 121 120 122 128 128 128 80 91 90 90 100 91 84 82 85 76 75 90 86 85 80 91 90 86 85 86 76 72 77 73 74 70 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 99% 99% 100% 100% 99% 98% 98% 98% 98% 99% 150 6 4 4 3 4 4 3 2 3 3 3 3 2 1 2 2 2 1 2 3 3 3 2 2 2 2 1 0
KALAIYARASI 31 F 58 160 A I APPENDICECTOMY 90/100% 86/100% 84/100% 85/100% 88/100% 85/100% 86/100% 86/100% 90 92 86 85 86 85 84 90 91 87 86 80 84 83 88 88 89 80 84 88 81 79 74 73 72 106 130 132 121 124 126 130 130 140 140 140 131 136 133 130 128 121 120 119 122 126 127 126 121 128 122 66 81 80 71 72 76 80 81 90 91 90 85 86 82 80 79 72 70 71 78 72 76 75 70 76 72 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 97% 97% 98% 98% 98% 99% 99% 99% 99% 98% 98% 99% 105 3 5 3 3 4 4 4 6 6 4 3 2 2 2 1 2 2 1 2 2 2 1 2 3 3 2 2 0
LALITHA 39 F 71 164 B I  INCISIONAL HERNIA 79/100% 75/100% 74/100% 71/100% 69/100% 65/100% 61/100% 66/100% 69 66 65 63 64 61 60 58 61 66 76 81 82 84 85 66 62 63 64 61 64 66 76 74 74 109 121 130 128 129 121 129 121 120 116 116 120 121 122 123 125 126 126 126 128 121 126 128 128 129 130 71 80 81 86 84 80 79 81 82 80 78 78 79 79 81 83 85 85 85 86 80 86 87 89 89 89 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 98% 98% 99% 99% 99% 100% 99% 99% 99% 100% 150 1 1 4 5 3 3 2 1 1 2 1 1 1 4 3 2 1 2 2 2 2 2 2 2 2 1 3 0
SUMANTH 18 M 66 162 A I  INCISIONAL HERNIA 80/100% 81/100% 84/100% 84/100% 80/100% 83/100% 82/100% 81/100% 78 96 85 67 63 66 68 96 98 84 85 84 83 84 75 73 72 71 71 70 69 72 74 76 78 120 112 114 120 118 119 101 108 127 130 132 130 128 129 132 129 125 124 120 118 119 118 119 119 119 121 76 72 75 76 75 79 61 63 85 86 88 85 84 83 84 80 80 81 82 79 79 77 75 76 73 79 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 98% 99% 99% 100% 100% 99% 98% 98% 98% 98% 99% 150 1 3 6 5 4 4 3 2 2 2 3 3 2 3 2 1 1 1 1 1 1 1 1 2 1 1 3 0
MASTER CHART
TIME TO
RESCUE
ANALGESIA
(HOURS)
VITALS AFTER DRUG -PREOP PR(beats/min)/Spo2(%) INTRAOP AND POSTOP VITALS POSTOP NUMERICAL RATING SCALE POSTOP  RAMSEY SEDATION SCORE
